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Chapter I 
 
Introduction 
 
 
The Vertebrate Retina as a Model for Studying CNS Development 
 
The central nervous system (CNS) is remarkably complex. There are 
approximately 86 billion neurons and 84 billion non-neuronal cells in the human 
brain (Azevedo et al., 2009). Given that individual neurons form hundreds to 
thousands of synaptic connections, the neocortex contains an estimated 0.15 
quadrillion synapses (Pakkenberg et al., 2003). Neuronal heterogeneity adds to 
this complexity. There are many different types of neurons; each subtype is 
characterized by different morphological, physiological, molecular, and synaptic 
properties. Normal CNS development and function requires specific cell types to 
be generated at the correct time and ratio, migrate, form precise connections, 
and integrate into networks. Therefore, understanding how the CNS develops is 
a very complicated task.  
The retina is a thin piece of light sensing tissue (~0.5mm thick), derived 
from the neural tube and located at the back of the eye. The retina is an 
anatomical extension of the brain. However, compared with the brain, the retina 
is a relatively simple and approachable part of the CNS. Moreover, the retina is 
the most widely studied and well-characterized part of the vertebrate brain 
(Dowling, 2012). Among vertebrates, the retina is precisely laminated and the 
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cytoarchitecture is evolutionarily very highly conserved. Retinal cells are 
stereotypically positioned and have distinct morphologies. Therefore, different 
cell types are distinguishable and subtle changes in developmental programs are 
easily detected as structural changes (Cepko et al., 1996). Importantly, retinal 
development and function are conserved across vertebrate species (Dowling, 
2012;(Stenkamp, 2015). The retina is easily accessible for experimental 
manipulations, and many of the intrinsic and extrinsic factors that temporally and 
spatially regulate all stages of retinal development are well characterized (Levine 
and Green, 2004; Yang, 2004; Agathocleous and Harris, 2009). For these 
reasons, the vertebrate retina has become a well-established and tractable 
model for investigating the cellular and molecular mechanisms that regulate 
developmental neurogenesis (Agathocleous and Harris, 2009).  
Basic Retinal Anatomy and Function 
The anatomy of the vertebrate retina was first described by Ramon y Cajal 
in the late 19th century. Using the Golgi staining technique, Cajal compared 
retinal histology and morphology across different species and noted the presence 
of distinct cell types in a conserved structure and organization (Cajal et al., 1972; 
Piccolino et al., 1989). There are five major types of neurons in the retina: 
photoreceptor cells, bipolar cells, horizontal cells, amacrine cells, and ganglion 
cells. The neural retina has a laminar structure with three distinct stratified 
cell/nuclear layers separated by two synaptic/plexiform layers. Each nuclear layer 
contains the cell bodies of specific cell types. The outer nuclear layer (ONL) 
contains the cell bodies of photoreceptor cells. The inner nuclear layer (INL) 
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contains cell bodies of bipolar, horizontal and amacrine interneurons. The 
ganglion cell layer (GCL) contains cell bodies of ganglion cells, which are the 
output neurons of the retina. Photoreceptors are photosensitive; they detect 
photons of light and carry out phototransduction, which is a process that converts 
light to biochemical then electrical signals for image-forming vision. There are 
two types of photoreceptor cells: rods and cones. Rods are extremely sensitive 
and detect dark, dim light (mostly at night). Cones are less sensitive than rods, 
detecting and distinguishing between a spectrum of light wavelengths, which 
provides the basis of daytime color vision. Some retinal ganglion cells are 
intrinsically photosensitive and are responsible for non-image-forming vision, 
such as measuring ambient light for synchronizing circadian rhythms and 
controlling pupil size (Fu et al., 2005). 
Visual perception originates in the eye. The retina receives and processes 
images, ultimately sending information collected from the visual scene to the 
vision centers in the brain. Visual processing begins when light is focused on the 
retina, traveling through the GCL and INL and activating the photoreceptors at 
the back of the retina. The signal is transduced back through the retina: 
photoreceptors synapse with bipolar cells (and horizontal cells) in the outer 
plexiform layer (OPL), and bipolar cells (and amacrine cells) synapse with 
ganglion cells in the inner plexiform layer (IPL). Horizontal and amacrine cells 
laterally regulate the input to and output of bipolar cells, respectively. The axons 
of ganglion cells form the nerve fiber layer or optic nerve, which transmits visual 
information to cortical areas in the brain.  
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The human retina contains three types of glial cells: Müller glia and 
astroglia (macroglia), and microglia (Vecino et al., 2016). Though both are 
neuroectodermal in origin, Müller glia are derived from retinal progenitor cells, 
while astroglia are not (Turner and Cepko, 1987; Wetts and Fraser, 1988). Müller 
glia are the primary glial cell of the retina; they provide structural, metabolic and 
homeostatic support and can serve as intrinsic stem cells (Bringmann et al., 
2006; Bernardos et al., 2007). The cell bodies of Müller glia are located in the INL, 
but the processes span radially across the entire retina from the inner limiting 
membrane to the outer limiting membrane (Bringmann et al., 2006). Astroglia 
enter the retina via the optic nerve and their presence is highly correlated with 
retinal vasculature patterning, such that avascular retinas do not contain 
astrocytes (Stone and Dreher, 1987; Watanabe and Raff, 1988; Vecino et al., 
2016). With cell bodies and processes located exclusively in the nerve fiber layer, 
astroglia regulate ganglion cell and blood retinal barrier homeostasis (Vecino et 
al., 2016). A major distinction between the human and fish retina is that the fish 
retina does not contain astroglia. Microglia are derived from mesodermal origins, 
located throughout the nuclear and synaptic layers of the retina, and act as 
immune cells (see more below; Vecino et al., 2016).  
Zebrafish as a Model Organism  
The zebrafish (Danio rerio, previously Brachydanio rerio) is a small 
tropical freshwater teleost fish of the Cyprinidae family. In the 1970s, George 
Streisinger and colleagues at the University of Oregon identified and developed 
zebrafish as a model organism (Streisinger et al., 1981). For a number of 
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reasons, the zebrafish is a powerful model organism to study vertebrate CNS 
development. First, zebrafish embryos are fertilized and develop externally inside 
a transparent chorion. Second, the embryos are relatively robust. Third, the eggs 
and embryos are also transparent throughout early development, allowing for 
direct visualization (observation and imaging) in vivo and in situ. Fourth, 
zebrafish are born in relatively large clutches. Zebrafish are photoperiodic 
breeders and mate soon after sunrise. Optimal breeding pairs can generate ≥200 
embryos per spawn. Fifth, the rate of zebrafish development is relatively rapid. 
When raised at 28.5°C, zebrafish progress from a fertilized egg to fully formed 
embryo within twenty-four hours. Within three days, larvae are hatched, 
swimming, and hunting and feeding. By three months, zebrafish are sexually 
mature adults. Hence, the generation time is relatively short (only 3-4 months). 
Sixth, zebrafish are easily maintained in the laboratory setting. Due to their 
relatively small size and propensity for living in large colonies, small spaces can 
house high densities (Brand et al., 2002). And, zebrafish husbandry is less 
expensive than rodent models. Seventh, zebrafish can be manipulated using a 
wide range of biochemical, genetic and molecular tools. They are well suited for 
large-scale genetic or mutagenesis and chemical screens. Finally, the zebrafish 
genome is fully sequenced and annotated (see 
ftp://ftp.ncbi.nlm.nih.gov/genomes/all/GCA_000002035.3_GRCz10/). There is at 
least one known zebrafish orthologue for 70% of all human genes (Howe et al., 
2013). Therefore, the zebrafish is an experimentally amenable model organism 
and powerful resource for genetic and developmental research.  
! 6!
The teleost retina is developmentally, morphologically, and functionally 
similar to other vertebrate retinas, including humans. And, many zebrafish 
mutants exist that model human retinal diseases. By studying the zebrafish retina, 
significant insights into the mechanisms regulating CNS development and 
disease can be made (Malicki, 1999; Glass and Dahm, 2004; Hitchcock and 
Raymond, 2004; Stenkamp, 2007; Fadool and Dowling, 2008). Advantageously, 
the zebrafish retina matures in a stereotyped spatial and temporal pattern, from a 
simple neuroepithelium to a functional retina by 72 hours post fertilization (hpf) 
(Easter and Nicola, 1996).  
Zebrafish Retinal Development 
Development of the retina is similar in all vertebrates (Chow and Lang, 
2001). However, compared with warm blooded vertebrates, retinal 
morphogenesis in zebrafish is very rapid (Schmitt and Dowling, 1994; Malicki, 
1999; Easter and Malicki, 2002). The zebrafish retina develops in three stages. 
The first stage begins at the end of gastrulation with the specification of retinal 
domains from a single field of dividing cells in the anterior neural keel that 
express eye field transcription factors, such as odd-paired-like (opl/zic1), retinal 
homeobox (rx1, rx2 and rx3), paired box protein (pax6), and sine oculis (Six3) 
(Chuang, 2001; Chuang and Raymond, 2002; Hitchcock and Raymond, 2004). 
The neural keel is a solid mass of cells akin to the neural tube in humans, and is 
also referred to as the neural plate. Around 12hpf, the eye field is split into two 
bilaterally evaginating optic primordia by Nodal and Sonic hedgehog signals 
emanating from the ventral midline (Macdonald et al., 1995; Masai et al., 2000). 
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At about 13hpf, the optic primordia flatten, proliferate and extend laterally, taking 
on a wing-like structure, and begin posteriorly detaching from the neural plate. 
Then the optic primordia, remaining anteriorly attached to the neural plate via the 
optic stalk, rotate from a horizontal to vertical orientation, and, around 15hpf, 
begin the transformation into eyecups through invagination (Easter and Malicki, 
2002). By 24hpf, eyecups have formed, and the retina is a layer of proliferating 
neuroepithelial cells (Schmitt and Dowling, 1994; 1999).  
The second stage of retinal development encompasses a series of 
neurogenic events, including cell proliferation, exit from the cell cycle, and 
differentiation. Retinal progenitors are a uniform population of multipotent cells 
that give rise to multiple distinct cell types (Agathocleous and Harris, 2009). From 
24 to 36hpf, retinal progenitors rapidly proliferate, expanding the retinal tissue 
(Schmitt and Dowling, 1999). The retina matures in a stereotyped spatiotemporal 
pattern. Post-mitotic, newly differentiated cells are incorporated into a precise 
and highly conserved laminar structure (Chow and Lang, 2001). At approximately 
28hpf, neuronal differentiation begins adjacent to optic stalk in a precocious 
ventronasal patch (Hu and Easter, 1999). Neuronal differentiation and lamination 
progress sequentially in inside-out, circumferential waves that move dorsally, 
then temporally (Schmitt and Dowling, 1996; 1999; Hitchcock and Raymond, 
2004). There are three waves of neurogenesis, each separated by a delay of 
approximately 10hrs (Hu and Easter, 1999; Stenkamp, 2007). First, between 28 
and 38hpf, ganglion cells exit the cell cycle. Then, from 38 to 48hpf, bipolar, 
horizontal, and amacrine cells in the INL terminally differentiate. Finally, between 
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48 and 60hpf, photoreceptor cells in the ONL are generated. Cones differentiate 
first, followed by rods. The zebrafish retina contains four different opsin-
expressing cone photoreceptors that differentiate in the order of their spectral 
subtype (red-green double cones, then UV and blue cones) and are arranged in 
a mosaic pattern (Raymond et al., 1993; 1995). Rods differentiate initially in a 
dense ventral patch, then become more sporadically interspersed between cones, 
and continue to accumulate throughout the life of the zebrafish from proliferating 
rod precursor cells in the ONL (Raymond, 1985). Müller glia are the last cells to 
differentiate. This histogenic birth order of retinal cells is largely conserved 
(Stenkamp, 2015). Relatively little cell death takes place in the embryonic 
zebrafish retina (Biehlmaier et al., 2001; Cole and Ross, 2001). By 72hpf, the 
initial phase of retinal neurogenesis is largely complete, and the retina is fully 
laminated and functional: newly hatched, 72hpf embryos respond to visual stimuli 
(Easter and Nicola, 1996).  
Unique to teleosts and amphibians, the third and final stage of retinal 
development is characterized by persistent retinal neurogenesis (Marcus et al., 
1999; Otteson and Hitchcock, 2003; Hitchcock et al., 2004). After the initial 
neuronal differentiation and lamination is complete, the retina continues to grow 
by the addition of new neurons from the ciliary marginal zone 
(CMZ)/circumferential germinal zone (CGZ) located at the peripheral edge 
between the retina and iris (Hitchcock et al., 2004; Hitchcock and Raymond, 
2004). Throughout the life of the zebrafish, new neurons are added to the retina 
in concentric annuli (Otteson and Hitchcock, 2003; Hitchcock et al., 2004; 
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Raymond et al., 2006). Remnant retinal stem cells in the CMZ/CGZ generate all 
retinal neurons, except rod photoreceptors, which are derived from rod 
progenitors in ONL and Müller glia in INL (Raymond, 1985). A fundamental 
feature of the zebrafish retina is that Müller glia are at the apex of the rod 
photoreceptor lineage. In the zebrafish retina, Müller glia act as retinal stem cells 
that can re-enter the cell cycle and divide asymmetrically to produce late-stage 
rod progenitors that in turn give rise to either rod or cone photoreceptors 
(Raymond et al., 2006; Bernardos et al., 2007). 
Eukaryotic Cell Cycle 
The eukaryotic cell cycle is a highly regulated process divided into phases 
based on cellular activity (Lodish et al., 2000). There are four sequential phases 
in the eukaryotic cell cycle: gap 1 (G1), synthesis (S), gap 2 (G2), and mitosis 
(M). During G1-phase, progenitors progress from M- to S-phase or permanently 
exit from the cell cycle and enter the arrested phase (G0). During S-phase, DNA 
is replicated. G2-phase of the cell cycle falls between DNA synthesis and the 
onset of cell division, and during M-phase cell division occurs. Cyclin/cyclin-
dependent kinase (CDK) complexes and CDK inhibitors, such as CDK inhibitory 
protein/kinase inhibitor protein (Cip/Kip) family members p27 and p57, regulate 
the progression through the different phases of the cell cycle (Dyer and Cepko, 
2001a; Bilitou and Ohnuma, 2010; Lim and Kaldis, 2013). Cyclin-CDK complexes 
promote cell cycle progression, whereas, CDK inhibitors prevent cell cycle 
progression and promote cell cycle exit (Dyer and Cepko, 2001a; 2001b; Bilitou 
and Ohnuma, 2010).  
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Retinal progenitors progress through and exit from the cell cycle in a 
spatially and temporally controlled manner (Li et al., 2000). Retinal progenitor 
proliferation, cell cycle exit, and differentiation are coordinated by complex 
interactions between intrinsic (competence) factors, such as transcriptional 
programs, and extrinsic (environmental) factors, such as soluble growth factors 
(Yang, 2004; Levine and Green, 2004). There are two main classes of 
transcription factors that intrinsically regulate retinal progenitor proliferation and 
differentiation: homeobox-containing, which includes retinal homeobox (rx), cone-
rod homeobox (crx), and paired box gene 6 (pax6), and basic helix-loop-helix 
(bHLH)-containing, which includes atonal homologue 5 (ath5/atoh7) and neuroD. 
Both rx and crx genes are expressed by mitotically active retinal progenitors, and 
promote differentiation of retinal progenitors, including photoreceptors (Chuang 
et al., 1999; Shen and Raymond, 2004). pax6 is expressed by proliferating retinal 
progenitors and retinal stem cells, and necessary for S-phase re-entry (Otteson 
and Hitchcock, 2003; Yi-Wen Hsieh, 2009). ath5/atoh7 is expressed by 
retinoblasts and required for the initiation of neurogenesis and ganglion cell 
differentiation (Masai et al., 2000; Kay et al., 2001; Kay, 2005). In the zebrafish 
retina, neuroD is expressed by mitotically active photoreceptor progenitors and 
nascent photoreceptors, and promotes cell cycle exit and photoreceptor genesis 
via the Notch signaling pathway (Hitchcock and Kakuk-Atkins, 2004; Ochocinska 
and Hitchcock, 2007; Taylor et al., 2015). 
In addition, multiple soluble or membrane-bound factors extrinsically 
regulate the rate at which zebrafish retinal progenitors progress through the cell 
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cycle. Notch/Delta signaling promotes retinal progenitor proliferation and inhibits 
neuronal differentiation (Scheer et al., 2001; Bernardos et al., 2005). Sonic 
hedgehog (Shh) signaling promotes cell cycle exit and is required for 
differentiation of multiple retinal neurons (Shkumatava and Neumann, 2005). Wnt 
signaling promotes progression through the cell cycle and maintains retinal 
progenitors in a proliferative state (Kubo, 2003; Kubo et al., 2005; Yamaguchi et 
al., 2005; Sánchez-Sánchez et al., 2010; Meyers et al., 2012). Further, there are 
numerous growth factors that act on the cell cycle during retinal neurogenesis. 
For example, the secreted growth factor, midkine-a (mdka), functions upstream 
of id2a to regulate cell cycle kinetics in retinal progenitors by negatively 
regulating Notch signaling (Luo et al., 2012; Uribe et al., 2012). 
There are multiple tools and assays available to study cell cycle kinetics in 
zebrafish (Shepard et al., 2004). Bromodeoxyuridine (BrdU) and 5-ethynyl-2'-
deoxyuridine (EdU) are thymidine analogues used to label cells during S-phase 
of the cell cycle. The DNA content of a cell can be measured using flow 
cytometry. Phospho-histone H3 (pH3) labels cells in M-phase of the cell cycle. 
Further, qRTPCR, Western blot, in situ hybridization and immunohistochemistry 
are used to assay the expression of cell cycle regulatory genes that promote cell 
cycle progression or cell cycle exit.  
 
Microglia 
 There are two major classes of glia in the vertebrate nervous system: 
macroglia—oligodendrocytes, schwann cells, and astrocytes, derived from 
neuroectoderm and also referred to as neuroglia—and microglia. In the 1920s, 
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the Spanish neuroscientist, Pio Del Rio-Hortega, introduced the concept of 
microglia, which were recognized at the time as part of a morphologically distinct 
“third element” of the CNS, in addition to neurons and neuroglia (Del Rio-Hortega, 
1937). From cytological observations, Rio-Hortega postulated microglia were a 
discrete macrophage population that derived from mesodermal origins and 
immigrated into nerve tissue during embryonic development. He noted microglia 
reside ubiquitously in the parenchyma of the mature brain and occupy discrete, 
non-overlapping spaces. Rio-Hortega discerned two distinct microglial 
morphologies: amoeboid, found in early developmental stages, and ramified, 
found at later stages. Following injury or under pathological conditions, he 
observed that microglia change back to an amoeboid-like morphology, migrate to 
the damaged area, proliferate, and become phagocytic. He concluded that the 
main physiological function of microglia is to uptake cellular debris and eliminate 
waste (Del Rio-Hortega, 1939). Almost all of Rio-Hortega’s initial seminal 
observations still hold true today. 
Origins and Development of Microglia 
Unlike neurons and neuroglial cells, microglia derive from non-neuronal 
lineages. Though the ontogeny of microglia was debated for many years 
(Cuadros and Navascués, 2001; Ginhoux and Prinz, 2015) , it is now established 
in fish (Herbomel, 2001), birds (Cuadros et al., 1993), and rodents (Ginhoux et 
al., 2010) that embryonic microglia originate as primitive yolk sac macrophages. 
In zebrafish, prior to the onset of blood circulation, macrophage precursors arise 
from ventro-lateral mesoderm and migrate into the yolk sac and differentiate; a 
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subset then enters the blood circulation, while a large proportion invade the 
cephalic mesenchyme between 22-40hpf (Herbomel et al., 1999). Once in the 
head, early macrophages invade nervous system tissues, including the brain and 
retina, between 30-48hpf, and then concurrently undergo a phenotypic 
transformation to become microglia around 60hpf (Herbomel, 2001). During 
embryonic development, migrating microglial precursors have an amoeboid 
morphology and are phagocytic (Svahn et al., 2012). The migration of microglial 
precursors into the developing CNS is highly conserved across vertebrate 
species (fish: Herbomel, 2001; rodents: Swinnen et al., 2013; humans: Verney et 
al., 2010).  
Studies using mice suggest that microglia derive from a single yolk sac 
origin (Ginhoux et al., 2010; Schulz et al., 2012). The prevailing view is that CNS 
microglia are established embryonically, and virtually no new microglia arise from 
exogenous sources, but are sustained through self-renewal in situ throughout 
adulthood instead (Ajami et al., 2007; Wohl et al., 2011; Bruttger et al., 2015). 
However, more recent evidence unambiguously demonstrates that, in zebrafish, 
embryonic/larval and adult microglial populations located in the brain and retina 
are derived from different progenitor pools, thus challenging the concept that 
microglia originate from a single embryonic source. Using light-induced high-
resolution fate mapping, researchers showed that in zebrafish embryonic/larval 
microglia arise from yolk sac macrophages produced by the rostral blood island 
(RBI), and adult microglia originate from progenitors in the ventral wall of the 
! 14!
dorsal aorta (VDA; Xu et al., 2015). Whether these findings hold true in mammals 
or are due to variations between species remains to be determined. 
Although the complex mechanisms that regulate macrophage migration 
and microglial maturation are not completely understood, these processes 
depend on multiple factors and are critical for normal CNS development and 
function. During CNS development, both cell autonomous factors expressed by 
the microglial lineage, including receptors and transcriptional programs, and non-
cell autonomous factors produced by neuroepithelial tissues, such as cell death 
signals and chemokines, can stimulate macrophage chemotaxis, drive 
differentiation, and promote microglial survival (Polazzi and Contestabile, 2002; 
Prinz and Priller, 2014; Schwarz and Bilbo, 2014). Below is a brief overview of 
key known factors.  
The colony-stimulating factor 1 receptor (CSF1R) is tyrosine kinase 
transmembrane receptor expressed by macrophages and CNS microglia (Byrne 
et al., 1981; Sawada et al., 1990). In mice, CSF1R is expressed throughout 
embryonic development, peaking postnatally and significantly reduced in the 
adult brain (Nandi et al., 2012). Csf1r knockout mice (Csf1r-/-) completely lack 
CNS microglia (Ginhoux et al., 2010; Erblich et al., 2011). Zebrafish panther 
mutants lack a functional fms gene, which encodes Csf1r (Parichy et al., 2000). 
In panther embryos, macrophages fail to migrate from the yolk sac into the 
embryonic brain and retina (Herbomel, 2001). Therefore, the migration of 
microglial precursors to the brain and retina is dependent on Csf1r (Pixley, 2012). 
There are two CSF1R ligands, CSF-1 and interleukin-34 (IL-34); both cytokines 
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are differentially expressed by neurons in distinct yet complementary brain 
regions (Lin et al., 2008; Wei et al., 2010; Nandi et al., 2012). CSF-1 is a known 
chemoattractant for macrophages (Webb et al., 1996; Pixley, 2012). Compared 
with CSF-1, IL-34 is more broadly expressed in the mouse brain and binds with 
greater affinity to CSF1R (Chihara et al., 2010; Nandi et al., 2012). In mice, 
knockout of either CSF-1 (Csf1op/op) or IL-34 results in decreased CNS microglia 
in distinct brain regions, but both phenotypes are less severe than the Csf1r-/- 
(Yoshida et al., 1990; Wegiel et al., 1998; Greter et al., 2012; Wang et al., 2012). 
A CSF-1/IL-34 double knockout mouse has not been generated. Whether CSF-1 
and IL-34 promote the differentiation and/or survival of microglia has been 
speculated (Metcalf, 1985; Lagasse and Weissman, 1997), but remains unknown.  
Microgliogenesis also requires Pu.1, Irf8, and Runx1 transcription factors. 
PU.1 is an ETS transcription factor encoded by the SPI1 gene (Rosenbauer and 
Tenen, 2007), expressed by hematopoietic cells, and required for microglial 
development; Pu.1 knockout mice (Pu.1-/-) completely lack CNS microglia (Beers 
et al., 2006; Kierdorf et al., 2013). In zebrafish, pu.1G242D mutants lack early RBI-
derived microglia, but not later VDA-derived microglia, suggesting pu.1 is 
differentially required for embryonic/larval and adult microglial development (Jin 
et al., 2012; Xu et al., 2015). Interferon regulatory factor-8 (IRF8) is a 
heterodimeric partner of Pu.1 that functions downstream of Pu.1; CNS microglia 
are significantly reduced in Irf8-deficient mice (Irf8-/-; (Kierdorf et al., 2013). The 
lack of microglia in both Pu.1-/- and Irf8-/- mice is due to decreased survival and 
maturation of yolk sac myeloid progenitors (Kierdorf et al., 2013). Runt-related 
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transcription factor 1 (RUNX1) binds to the Pu.1 promoter and inhibits Pu.1 
expression in a negative feedback loop (Jin et al., 2012). In zebrafish, 
overexpression of Runx1 inhibits macrophage/microglial precursor formation, 
whereas the number of microglia is significantly increased in runx1w84x mutants 
(Jin et al., 2012). Further, in zebrafish, Runx1 is required for the development of 
the VDA-derived adult microglial population (Xu et al., 2015). In mice, Runx1 
regulates microglial proliferation and homeostasis in the postnatal brain (Ginhoux 
et al., 2010; Zusso et al., 2012). And, recent studies demonstrated microRNAs 
(miRs), such as miR-124, post-transcriptionally regulate microglial development 
and functional maturation (Svahn et al., 2015). 
Zebrafish mutant screens are a powerful resource for identifying 
microgliogenesis factors in vivo and have recently yielded several novel 
regulators of microglial precursor migration and differentiation. The 
Leucine/Arginine transporter, slc7a7, is expressed by a distinct sub-lineage of 
primitive macrophages in the anterior lateral plate mesoderm precommitted to 
give rise to microglia, and necessary for macrophage colonization of the 
zebrafish brain and retina (Rossi et al., 2015). The zebrafish orthologue of 
phosphate exporter XPR1, xpr1b, is autonomously required for primitive 
macrophages colonize the CNS parenchyma and differentiate to microglia 
(Meireles et al., 2014). Further, noncanonical NOD-like receptor (nlrc3-like) acts 
cell autonomously and is required for migration of primitive macrophages into the 
zebrafish CNS (Shiau et al., 2013). Zebrafish slc7a7, xpr1b, and nlrc3-like 
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mutants all lack microglia (Shiau et al., 2013; Meireles et al., 2014; Rossi et al., 
2015).  
Microglial Function 
Microglia are mononuclear cells that are ubiquitously, but not uniformly, 
distributed throughout the CNS parenchyma, occupying discrete territories, and 
comprising between 5-12% of all cells in the CNS (Lawson et al., 1990). The two 
main functions of microglia are CNS immune defense and homeostasis. 
Microglial function in the retina is the same as in the brain (Provis et al., 1996; 
Cuoghi and Mola, 2007; Langmann, 2007; Dick, 2008; Karlstetter et al., 2010; 
Fischer et al., 2014; Noailles et al., 2014; Fischer et al., 2015; Li et al., 2015). 
Historically considered the resident macrophages or primary immune cells of the 
CNS (Butovsky et al., 2006; Walton et al., 2006; Hanisch and Kettenmann, 2007; 
Peri and Nüsslein-Volhard, 2008; Saijo and Glass, 2011; Shigemoto-Mogami et 
al., 2014), microglia are very sensitive to their environment. Detection of 
homeostatic disturbances, such as invading pathogens or damaged and dying 
neurons, induces rapid microglial ‘activation’. In the context of brain injury and 
disease, microglia retract their processes and take on an amoeboid morphology. 
In this activated or reactive state, microglia proliferate, migrate to and invade the 
site of injury, increase surface antigen expression, phagocytose cellular debris, 
and secrete numerous diffusible factors, such as chemokines, cytokines and 
growth factors as part of the immune response (Kettenmann et al., 2011; 
Tremblay et al., 2011; Sieger et al., 2012; Prinz and Priller, 2014). Activated 
microglia are pathological markers of many neurodegenerative diseases, 
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including Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s disease (AD) and 
Parkinson’s disease (PD) (Brouwers et al. 2007 & 2008; Sleegers et al. 2008; 
Viswanathan et al. 2009).  
 Whether microglial activation is a beneficial or harmful response to CNS 
injury or disease has been debated for many years (Streit et al., 1999; 
Kempermann, 2003; Hanisch and Kettenmann, 2007; Ekdahl et al., 2009; 
Tremblay and Sierra, 2014). Some studies demonstrate that activated microglia 
secrete neurotoxic factors, exacerbating neuronal damage, and that microglial 
activation negatively correlates with neurogenesis (Streit et al., 1999; Hanisch, 
2002; Ekdahl et al., 2003; Monje et al., 2003; van Rossum and Hanisch, 2004; 
Rice et al., 2015). While, contrary evidence reveals activated microglia secrete 
neurotrophic factors, and microglial activation is a response to neuronal damage, 
not a cause, and positively correlates with neurogenesis, playing a necessary 
neuroprotective and/or regenerative role (Miwa et al., 1997; Nakajima et al., 
2001; Streit, 2002; Nakajima and Kohsaka, 2004; Battista et al., 2006; Butovsky 
et al., 2006; Simard and Rivest, 2006; Ziv et al., 2006; Fischer et al., 2014; 
Shigemoto-Mogami et al., 2014). Nevertheless, microglial activation is variable, 
context-dependent, and adaptable (Colton, 2009), and more research is needed 
to understand the heterogeneity of microglial responses to CNS injury and 
disease.   
In the normal adult CNS, microglia are classified as inactive or resting. 
However, unlike the name suggest, resting microglia are not passive or dormant 
cells, but in fact dynamically extend and retract their ramified processes, 
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continuously surveying their environment (Davalos et al., 2005; Nimmerjahn, 
2005; Svahn et al., 2012). Resting microglia are emerging as critical components 
of CNS homeostasis and plasticity. In zebrafish, in vivo time-lapse imaging 
demonstrates that resting microglia respond to increases in neuronal activity by 
directing their processes toward and making contact with the cell bodies of active 
neurons (Li et al., 2012); and microglial contact subsequently leads to 
downregulation of spontaneous activity in the contacted neuron (Li et al., 2012; Ji 
et al., 2013). In adult mice, microglial depletion attenuates performance on 
learning and memory tasks and learning-dependent synapse remodeling 
(Parkhurst et al., 2013). Further, in vivo two-photon imaging of visual cortex in 
monocularly deprived mice demonstrated that microglial processes interact with 
synapses in an activity-dependent manner (Wake et al., 2009; Li et al., 2012; 
Sipe et al., 2016); and pharmacologically or genetically blocking microglial 
process motility inhibits ocular dominance plasticity (Sipe et al., 2016). These 
studies strongly implicate resting microglia in homeostatic regulation of neuronal 
activity and synaptic plasticity in the adult brain. 
Evidence of the neurogenic role microglia play in the adult brain is 
increasing. Mutations in microglia-specific genes are associated with neurological 
disorders, including AD, FTD, and MS, suggesting microglia are important 
regulators of normal brain physiology (De Jager et al., 2009; Adam C Naj et al., 
2011; Hollingworth et al., 2011; Griciuc et al., 2013; Guerreiro et al., 2013). In the 
adult mammalian brain, microglia are elements of the neurogenic stem cell niche 
(Ninkovic and Götz, 2007). In adult mice, microglia promote neural progenitor 
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survival and migration in the subventricular zone (Ribeiro Xavier et al., 2015), 
and are required for exercise-induced neural precursor cell activation in the 
hippocampus (Vukovic et al., 2012).  
In addition to their homeostatic and neurogenic functions in the adult brain, 
microglia regulate multiple aspects of CNS development. In vivo, microglia 
regulate the size of the neural progenitor pool in embryonic rat SVZ 
(Cunningham et al., 2013). Microglia promote neuronal survival in the developing 
post-natal brain by releasing neurotrophic factors (Ueno et al., 2013). During 
CNS development, microglia promote programmed cell death (Marín-Teva et al., 
2011), and actively regulate activity-dependent synaptic pruning, maturation and 
remodeling (Paolicelli et al., 2011; Schafer et al., 2012; Bilimoria and Stevens, 
2014; Sato, 2015). Multiple developmental brain abnormalities are found in Csf1r 
-/- mice that lack microglia, including small brains, increased neuronal density and 
decreased cortical thickness (Nandi et al., 2012). Csf1r-/- mice do not live beyond 
one month of age (Dai et al., 2004). In vitro, proliferation is reduced in embryonic 
neural precursors from Pu.1-/- mice (Antony et al., 2011). In vitro, microglia can 
induce neurogenesis (Walton et al., 2006). An increase in neurogenesis occurs 
when neural progenitors are either co-cultured in media-connected chambers 
with microglia (Nikolakopoulou et al., 2013) or cultured with microglia-conditioned 
medium (Morgan et al., 2004; Walton et al., 2006; Antony et al., 2011), which 
strongly implicates that factors expressed and secreted by microglia regulate 
neurogenic events. Further investigations into the role microglia and/or their 
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secreted factors play during early neurogenic events in vivo are an important and 
necessary area of research. 
 
Progranulin 
 
Progranulin (PGRN) is an evolutionarily conserved secreted growth 
factor/pleiotropic glycoprotein precursor (Baba et al., 1993; Cadieux et al., 2005). 
PGRN was identified by several research groups working independently, and as 
a result has several synonymous names. PGRN is also known as granulin-
epithelin precursor (Bhandari and Palfree, 1992; Plowman et al., 1992), 
proepithelin (Plowman et al., 1992), acrogranin (Baba et al., 1993), and PC cell-
derived growth factor (Zhou et al., 1993). Mammalian genomes contain one 
progranulin gene (GRN/Grn), which, in humans, is located on chromosome 17 
and contains twelve protein-coding exons (Bhandari and Palfree, 1992). 
Structurally related to the epithelin growth factor family, GRN is made up of 
seven and a half tandem repeats of twelve-cysteine granulin/epithelin motifs 
(Bhandari and Palfree, 1992; Bateman and Bennett, 1998). Once secreted, the 
68kDa PGRN protein is heavily glycosylated to 90kDa, then enzymes, such as 
protease-3, elastase, and metalloproteinases, can proteolytically cleave PGRN 
into smaller (6kDa) peptide fragments called granulins (Zhou et al., 1993; Zhu et 
al., 2002; Kessenbrock et al., 2008; Suh et al., 2012). Secreted leukocyte 
protease inhibitor (SLPI) can bind to and inhibit proteolysis of secreted PGRN 
(Zhu et al., 2002). Both PGRN and individual granulins have biologically 
functional properties (Shoyab et al., 1990), though the majority of research, 
including this thesis, focuses on the intact precursor (Toh et al., 2011).  
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There are two putative receptors for Pgrn: tumor necrosis factor receptor 
(TNFR) and sortilin (Hu et al., 2010; Tang et al., 2011). Sortilin was identified 
through unbiased ligand binding assays and expression cloning as a neuron-
specific PGRN receptor (Hu et al., 2010), though microglia-specific Sortilin 
expression has been demonstrated both in vitro (Dicou et al., 2004; Hu et al., 
2010) and in vivo (Reuter et al., 2015). As an endocytic and intracellular sorting 
receptor, Sortilin is a known mediator of protein trafficking between the cell 
surface and various intracellular compartments (Hermey, 2009). Sortilin-
mediated endocytosis and lysosomal targeting of PGRN is thought to regulate 
extracellular and intracellular PGRN levels (Hu et al., 2010). A study using yeast 
two-hybrid screening identified direct binding between PGRN and TNFR1 and 
TNFR2 (Tang et al., 2011). Further, when bound to the TNFR, PGRN 
antagonizes TNFα signaling and results in anti-inflammatory effects (Tang et al., 
2011). 
The Function of Progranulin in Peripheral Tissues 
PGRN is a multifunctional protein, with well-established roles in vertebrate 
embryogenesis, tumorigenesis and wound healing (He and Bateman, 2003; He 
et al., 2003; Ong and Bateman, 2003). PGRN was first identified as a novel 
autocrine growth factor in transformed cell lines (Zhou et al., 1993). Subsequent 
studies established that in peripheral tissues and tumor cells, PGRN is mitogenic, 
stimulates cell proliferation and migration, and promotes cell survival (He et al., 
2002; He and Bateman, 2003; Ong and Bateman, 2003). PGRN is primarily 
expressed by gametes, hematopoietic cells, and mitotically active epithelial cells 
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(Bateman and Bennett, 1998). Ex vivo studies demonstrated that PGRN is 
secreted by the blastocyst and regulates early embryo formation and 
development in mammals (Díaz-Cueto, 2000; Qin, 2005). In vitro, exogenous 
application of recombinant PGRN to mouse embryos eight-cell stage accelerates 
cavitation onset, stimulates blastocoel expansion, increases trophectoderm cell 
number, and promotes blastocyst hatching, adhesion, and outgrowth during 
implantation (Díaz-Cueto, 2000; Qin, 2005). Conversely, inhibition of PGRN with 
function-blocking antibodies significantly inhibits embryo development to the 
blastocyst stage (Díaz-Cueto, 2000; Qin, 2005).  
PGRN is highly expressed in many different types of tumors, including 
renal (Donald et al., 2001), liver (Cheung et al., 2004; Ho et al., 2008), 
gastrointestinal (Demorrow, 2013), breast (Lu and Serrero, 2001; Serrero and 
Ioffe, 2003; Tangkeangsirisin and Serrero, 2004; Koo et al., 2012), ovarian 
(Jones et al., 2003; Han et al., 2011), prostate (Pan et al., 2004), bladder 
(Monami et al., 2006), esophageal (Chen et al., 2008), and neuroglial (Liau et al., 
2000; Wang et al., 2011). The level of PGRN expression is directly proportional 
to proliferation rate of transformed cells in vitro and tumorigenicity in vivo, such 
that increased PGRN levels accelerates cell division (He and Bateman, 1999) 
and decreasing PGRN levels attenuates tumor growth (Zhang and Serrero, 
1998). In vitro, PGRN promotes migration and invasiveness of transformed cells 
(Tangkeangsirisin and Serrero, 2004; Monami et al., 2006; Swamydas et al., 
2011; Dong et al., 2015). Further, PGRN inhibits apoptosis of tumor cells 
(Tangkeangsirisin and Serrero, 2004; Monami et al., 2006); in vitro, inhibition of 
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PGRN with neutralizing antibodies increases ovarian cancer cell apoptosis 
(Kamrava et al., 2005). For these reasons, PGRN may be used as a prognostic 
biomarker in tumorigenesis (Han et al., 2011; Koo et al., 2012).  
Following cutaneous wounding, PGRN, which is normally at undetectable 
levels, is strongly induced in injured fibroblasts and endothelial cells and 
upregulated in infiltrating neutrophils and macrophages (Zhu et al., 2002; He et 
al., 2003). In vitro, PGRN stimulates proliferation and migration of endothelial and 
fibroblast cells; in vivo, application of PGRN to a cutaneous wound results in an 
increase in macrophage, neutrophil, and blood vessel accumulation in the wound 
(He et al., 2003). These findings suggest PGRN may also function as a paracrine 
growth and chemotactic factor. In vivo, administration of recombinant PGRN 
inhibits inflammation and promotes re-epithelialization and wound healing (Zhu et 
al., 2002; Kessenbrock et al., 2008; Tang et al., 2011). Factors that regulate cell 
proliferation must ultimately exert their effects on the cell cycle. Acting as both a 
competence and progression factor, PGRN promotes mitosis in embryonic and 
adult epithelial cells by stimulating classic growth factor signal transduction 
cascades, such as mitogen-activated protein kinase (MAPK)/extracellular-signal-
related kinase (ERK) and phosphatidylinositol 3-kinase (PI3K) pathways 
(Zanocco-Marani et al., 1999; Ong and Bateman, 2003; Bateman and Bennett, 
2009). 
The Function of Progranulin in the CNS 
Much is known about PGRN activity in non-neuronal tissues, however the 
function of PGRN within the CNS is not well understood. In the normal adult 
! 25!
mammalian CNS, neurons and microglia express PGRN at relatively low levels 
(Daniel et al., 2000). Evidence of the neurogenic role PGRN plays in the adult 
brain is increasing. In vivo, PGRN increases voluntary exercise-induced 
neurogenesis in the hippocampus of adult mice (Asakura et al., 2011). In the 
mouse middle cerebral artery occlusion model of ischemia, overexpression of 
PGRN in the brain rescues motor and neurological deficits (Tao et al., 2012). 
Further, in the adult mouse retina, PGRN regulates retinal progenitor proliferation 
and photoreceptor differentiation following retinal damage (Kuse et al., 2016).  
In humans, diminished PGRN production due to heterozygous mutations 
in the PGRN gene (hGRN) is a major cause of the neurodegenerative disease, 
Frontotemporal Lobar Degeneration (FTLD) (Baker et al., 2006; Cruts et al., 
2006). FTLD leads to Frontotemporal Dementia (FTD). FTD is the second most 
common cause of dementia in individuals under 65 years of age 
(http://www.theaftd.org/understandingftd/diagnosis). Characterized by bilateral 
atrophy of the prefrontal and anterior temporal neocortical lobes and non-
Alzheimer disease-type pathology, FTD results in progressive cognitive and 
motor deficits (Neary et al., 2005). FTD is a behavioral disorder with an early 
insidious onset and clinical diagnostic features including lack of social and 
personal awareness, emotional blunting, mental rigidity and inflexibility, and 
altered speech (Brun et al., 1994). FTD affects men and women equally and is 
strongly heritable. Approximately 40% of FTD patients have a family history of 
FTD or other related dementia; 5-10% show an autosomal dominant inheritance 
pattern (Chow et al., 1999; Bird et al., 2003; Rosso, 2003; Goldman, 2005; 
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Seelaar et al., 2008). Autosomal dominant FTD is most commonly linked to 
mutations in microtubule associated protein tau (MAPT) or GRN, located one 
megabase apart on chromosome 17 (Baker et al., 2006; Cruts et al., 2006). 
Scientists have identified over 60 mutations in the GRN gene, accounting for 
10% of all FTD patients and approximately 20% of familial FTD (Baker et al., 
2006; Cruts et al., 2006; Gass et al., 2006). Mutations in GRN often create null 
alleles, resulting in rapid degradation of GRN mRNA, reduced levels of PGRN 
and haploinsufficiency (Cruts et al., 2006).  Missense mutations in GRN can 
result in the production of truncated, non-functional or unstable PGRN (van der 
Zee et al., 2007). Interestingly, FTLD patients with GRN mutations also display 
early disease retinal thinning that preceeds FTD onset (Ward et al., 2014). A 
mouse model of PGRN haploinsufficiency (Grn+/− and Grn−/−) recapitulates 
aspects of FTD, including abnormal behavior, lipofuscinosis and 
neurodegeneration, inflammation, gliosis, and retinal degeneration in adults 
(Kayasuga et al., 2007; Ahmed et al., 2010; Ward et al., 2014) Yin et al., 2010; 
Wils et al., 2012; Ghosal et al., 2012; Filiano et al., 2013; Gotzl et al., 2014). 
However, CNS development has yet to be studied in Grn+/− and Grn−/− mice. The 
preponderance of research on the function of PGRN within the CNS focuses on 
understanding how life-long reductions in PGRN leads to neurodegeneration and 
dementia later in life. Yet, the mechanisms remain unknown.  
While decreased PGRN results in FTLD, upregulation of PGRN in the 
CNS is associated with brain cancer and injury. In human glioma tumor cells, 
PGRN expression levels are consistently and significantly increased (up to 30 
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fold) compared with normal brain tissue (Liau et al., 2000). Similar to peripheral 
tissue tumors, elevated PGRN expression is correlated with increased 
recurrence and decreased survival rate in patients with glioblastoma (Wang et 
al., 2011). PGRN is a molecular signature of activated microglia (De Muynck and 
Van Damme, 2011); CNS injury and disease induces a microglia-specific 
upregulation of progranulin message and protein expression (Craig et al., 2008; 
Moisse et al., 2009; Naphade et al., 2009; Philips et al., 2010). Furthermore, in 
vitro, PGRN acts as a microglial chemoattractant (Pickford et al., 2011). 
Therefore, modulation of PGRN levels in the brain plays an important role in CNS 
disease pathogenesis.  
 Evidence of the neurogenic role PGRN plays in the normal developing 
brain is increasing. In mice, PGRN is initially highly expressed by embryonic 
neuroepithelial cells, and then becomes restricted to fetal forebrain, olfactory 
bulbs, retinal ganglion cells, and spinal cord (Daniel et al., 2000; 2003). Early 
expression by neuroepithelial cells suggests PGRN plays a role in CNS 
development. In rats, PGRN is expressed in the neonatal hypothalamus and 
regulates sexual dimorphism and differentiation of the brain (Suzuki and 
Nishiahara, 2002). In vitro, in rat cortical and spinal motor neurons, recombinant 
PGRN enhances cell survival and increases neurite outgrowth length in a dose-
dependent manner (Van Damme et al., 2008). Compared with wild type, neurite 
outgrowth and branching is significantly reduced in primary neuronal cultures 
from Grn-/- mice (Gass et al., 2012). Transfection of hGRN into NSC-34 motor 
neuron-like cells increases the formation of neurite processes and cell survival; 
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shRNA knockdown of PGRN decreased neuronal cell proliferation and survival 
(Ryan et al., 2009). PGRN-induced neurite outgrowth in primary mouse 
hippocampal and cortical neuron cultures requires glycogen synthase kinase 3β 
(GSK3β) signaling (Gao et al., 2010). Similarly, PGRN-dependent 
phosphorylation of GSK3β induces proliferation of mouse cultured neural 
progenitor cells (Van Damme et al., 2008; Ryan et al., 2009; Gao et al., 2010; 
Nedachi et al., 2011). Extracellular PGRN protects rat primary cortical neuron 
cultures from glutamate- or oxidative stress-induced cell death by activating 
MEK/ERK/p90RSK and PI3K/Akt signaling pathways (Xu et al., 2011). Together, 
these studies highlight the potential neurotrophic effects of PGRN. However, 
much remains to be determined about the function of PGRN in vivo in the 
developing CNS.  
Zebrafish Progranulin Gene Family 
Cadieux and colleagues performed initial characterization of the zebrafish 
progranulin gene family (Cadieux et al., 2005). The zebrafish genome contains 
four protein-encoding progranulin genes: progranulin-1 (pgrn-1), progranulin-2 
(pgrn-2), progranulin-a (pgrn-a), and progranulin-b (pgrn-b). These four 
paralogues display two distinct structures. The first is exemplified by pgrn-1 and 
pgrn-2, both of which contain five exons that encode one and a half granulin 
domains. In addition, the predicted Pgrn-1 and Pgrn-2 protein sequences do not 
contain glycosylation sites. The second structural type is represented by pgrn-a 
and pgrn-b, which are made up of eighteen and fifteen coding exons that encode 
ten and nine granulin domains, respectively. pgrn-a and pgrn-b share 
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approximately 49% sequence homology, and are at least 45% and 43% 
homologous to hGRN, respectively. Therefore, pgrn-a and pgrn-b are both co-
orthologues of mammalian GRN. The fact that zebrafish possess two co-
orthologues of mammalian GRN is likely due to a pan-genomic duplication event 
(Taylor et al., 2003). Based on chromosomal location, only pgrn-a is syntenically 
conserved, making it the true orthologue of hGRN. RT-PCR analysis 
demonstrates pgrn-a and pgrn-b transcripts are maternally provided and continue 
to be expressed throughout development, from cleavage to 96hpf. In adult 
zebrafish, pgrn-a and pgrn-b transcripts are detected in many tissues, including 
skin, gills, heart, blood, intestine, pancreas, spleen, pronephros, and brain 
(Cadieux et al., 2005).  
There are several studies published on the function of Pgrn-a in zebrafish. 
pgrn-a is upregulated in injured heart muscle, suggesting it may play a regulatory 
role in heart regeneration (Lien et al., 2006). Our lab identified pgrn-a in the 
zebrafish retina through an unbiased screen for genes modulated during 
neuronal regeneration in the adult retina; pgrn-a is expressed exclusively by 
microglia in the adult zebrafish retina, and is significantly upregulated in retinal 
microglia after photolytic lesion and during photoreceptor regeneration (Craig et 
al., 2008). These data suggest that pgrn-a may also regulate retinal regeneration. 
pgrn-a message and protein are expressed in caudal primary motor neurons and 
purportedly regulates motor neuron development (Chitramuthu et al., 2010). 
Knockdown of Pgrn-a attenuates motor neuron axonal outgrowth and branching, 
and Pgrn-a overexpression rescues the knockdown-induced axonopathy (Laird et 
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al., 2010). Pgrn-a knockdown also results in decreased hepatic outgrowth, 
suggesting Pgrn-a may potentially play a regulatory role in liver morphogenesis 
(Li et al., 2010). Pgrn-a is expressed in myogenic progenitor cells (MPCs), and 
reduction of Pgrn-a decreases MPC proliferation during postembryonic muscle 
growth and following muscle injury, therefore Pgrn-a regulates aspects of muscle 
growth and regeneration (Li et al., 2013). However, single and double pgrn-a/b 
mutant (pgrna-/-, pgrnb-/-, and pgrna-/-pgrnb-/-) fish lines generated using zinc 
finger nuclease genome editing technology did not recapitulate spinal motor 
neuron axonopathy and MPC phenotypes reported in the aforementioned 
knockdown experiments (Solchenberger et al., 2015). Loss of Pgrn-b function 
produces no developmental phenotype (Shankaran et al., 2008). The function of 
Pgrn-a in the developing CNS remains unknown and is an interesting and 
important area of research. 
The main goal of my thesis research is to use zebrafish retinal 
development as a model to test the hypothesis that microglia and the factors they 
express and secrete play a fundamental role in vertebrate neurogenesis. A 
second goal is to generate tools, specifically transgenic and mutant fish lines, to 
enable further study of the function of microglia and Pgrn-a in the developing and 
injured/regenerating retina. In chapter two, I present data that demonstrate the 
requirement of microglia for early neurogenic events in the retina, using genetic 
and pharmacological models. I also describe!the temporal and spatial expression 
pattern of pgrn-a during embryonic retinal development, and characterize the 
function of Pgrn-a in developmental neurogenesis using a loss-of-function 
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approach. This chapter is a largely unabridged version of the manuscript 
submitted to the journal Glia titled, “Microglia and Progranulin regulate 
neurogenesis in the developing vertebrate retina” by Caroline E. Walsh and Peter 
F. Hitchcock. In chapter three, I present data on the downstream signaling 
mechanisms of Pgrn-a. I also summarize the rationale behind and progress 
made towards generating 1) a BAC transgenic line to use as a Pgrn-a reporter 
and to study the function of microglia in the zebrafish retina, and 2) a CRISPR 
mutant line to study the function of pgrn-a in retinal development and 
regeneration. Finally, in chapter four, I discuss concluding insights from my work 
on retinal development in vertebrates, microglia and progranulin, summarize the 
limitations of the methodology/technology and model, highlight remaining 
questions, and propose possible future directions to address these questions.   
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Chapter 2: Microglia and Progranulin Regulate Neurogenesis in the 
Developing Vertebrate Retina 
 
ABSTRACT  
 
 We used independent genetic and pharmacological approaches to 
determine the role of microglia and their secreted factors during developmental 
neurogenesis in the embryonic retina of zebrafish. When microglia are excluded 
from the retina, neurogenesis is significantly delayed - retinal progenitors fail to 
exit the cell cycle at the appropriate developmental time, and postmitotic cells do 
not acquire markers of terminal differentiation. We also evaluated the expression 
and function of the microglia-specific growth factor, Progranulin-a (Pgrn-a). At 24 
hpf pgrn-a is expressed throughout the forebrain, but by 48 hpf pgrn-a is 
exclusively expressed by microglia and/or microglial precursors within the brain 
and retina. Knockdown of Pgrn-a does not alter the onset of neurogenic 
programs or increase cell death, however its absence prevents microglial 
precursors from colonizing the retina, and results in a concomitant delay in 
neuronal differentiation. Given the link between Progranulin and cell cycle 
regulation in peripheral tissues and transformed cells, we analyzed cell cycle 
kinetics among retinal progenitors following Pgrn-a knockdown. Depleting Pgrn-a 
results in a significant lengthening of the cell cycle. These data suggest that 
Pgrn-a plays a dual role during nervous system development by both attracting 
microglial progenitors into the embryonic brain and retina and by governing the
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 rate at which progenitors progress through the cell cycle. Collectively, these data 
show that the presence of microglia in the embryonic CNS and/or the molecules 
they secrete govern neurogenesis by regulating cell cycle kinetics and the 
transition from proliferation to cell cycle exit and differentiation.  
 
INTRODUCTION 
 Microglia were first described by Pio del Rio Hortega in the 1920s (Del Rio 
Hortega, 1939). Though classically thought of as resident macrophages or 
immune cells of the central nervous system (CNS), microglia are morphologically 
and functionally heterogeneous (Kettenmann et al., 2011; Prinz and Priller, 2014). 
Microglia are highly ramified, motile cells that actively survey the CNS 
parenchyma (Nimmerjahn et al., 2005; Hanisch and Kettenmann, 2007). In the 
context of brain injury and disease, microglia respond by adopting an amoeboid 
‘activated’ phenotype, phagocytosing cellular debris, and secreting numerous 
cytokines and growth factors as part of the inflammatory response (Garden and 
Möller, 2006; Hanisch and Kettenmann, 2007). Unlike neurons and other glial 
cells, which originate from the neuroepithelium, microglia derive from a subset of 
primitive yolk sac macrophages that migrate into neuroepithelial tissues, colonize 
the CNS parenchyma and undergo a phenotypic transformation (Herbomel et al., 
1999; Herbomel et al., 2001; Ginhoux et al., 2010). In addition to their 
homeostatic functions in the adult brain, microglia also regulate aspects of CNS 
development and function, including the proliferation of neural progenitors, 
neuronal survival, neural patterning, programmed cell death, and the pruning, 
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maturation and function of synapses (Reviewed in Bilimoria and Stevens, 2014; 
Sato, 2015). Further, microglia in vivo are elements of the stem cell niche 
(Ninkovic and Götz, 2007), and microglia in vitro can induce gliogenesis and 
neurogenesis (Butovsky et al., 2006; Walton et al., 2006; Shigemoto-Mogami et 
al., 2014). Interestingly, an increase in neurogenesis occurs when neural 
progenitors are either cultured with microglia in media-connected chambers 
(Nikolakopoulou et al., 2013) or cultured with microglia-conditioned medium 
(Morgan et al., 2004), demonstrating that factors secreted by microglia regulate 
neurogenic events. 
 Progranulin (PGRN), also known as granulin-epithelin precursor, 
acrogranin, proepithelin and PC cell-derived growth factor, is an evolutionarily 
conserved secreted growth factor/pleiotropic glycoprotein precursor with a well 
established role in embryogenesis, tumorigenesis and wound healing (He and 
Bateman, 2003; He et al., 2003; Ong and Bateman, 2003). In peripheral tissues 
and tumor cells, PGRN is mitogenic, stimulates cell proliferation and migration, 
and promotes cell survival (He et al., 2002; He and Bateman, 2003; Ong and 
Bateman, 2003). In the mammalian CNS, PGRN is expressed by neurons and 
microglia (Daniel et al., 2000). In humans, diminished PGRN production due to 
heterozygous mutations in the PGRN gene (hGRN) is a major cause of the 
neurodegenerative disease, Frontotemporal Lobar Degeneration (FTLD) (Baker 
et al., 2006; Cruts et al., 2006). In contrast, malignancy of glioblastomas is 
correlated with elevated PGRN levels (Liau et al., 2000; Wang et al., 2011). In 
vivo, PGRN increases exercise-induced neurogenesis in the hippocampus of 
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adult mice (Asakura et al., 2011). In vitro, PGRN enhances neuronal survival, 
increases neural progenitor proliferation, and promotes neurite outgrowth and 
neuronal differentiation (Van Damme et al., 2008; Ryan et al., 2009; Gao et al., 
2010; Nedachi et al., 2011). PGRN is a molecular signature of activated microglia 
(De Muynck and Van Damme, 2011); CNS injury induces a microglia-specific 
upregulation of progranulin message and protein expression (Craig et al., 2008; 
Moisse et al., 2009; Naphade et al., 2009; Philips et al., 2010). Interestingly, in 
vitro PGRN acts as a microglial chemoattractant (Pickford et al., 2011). Much is 
known about PGRN activity in non-neuronal tissues and the injured CNS, 
however the function of PGRN within the developing CNS is not well understood. 
We use the zebrafish retina as a model tissue for studying brain 
development. The vertebrate retina is a well-established and tractable model for 
investigating the cellular and molecular mechanisms that regulate both 
developmental and regenerative neurogenesis (Agathocleous and Harris, 2009). 
Among vertebrates, the cytoarchitecture of the retina is precise and evolutionarily 
very highly conserved. Even subtle changes in developmental programs are 
easily detected as structural changes (Cepko et al., 1996). Zebrafish have four 
protein-encoding progranulin genes, two of which, pgrn-a and pgrn-b, are co-
orthologues of mammalian gene (GRN) (Cadieux et al., 2005). pgrn-a is 
syntenically conserved, making it the true orthologue of hGRN. We first identified 
pgrn-a as a microglia-specific growth factor in the retina of the adult zebrafish, 
where it is strongly upregulated following photoreceptor death and during 
photoreceptor regeneration (Craig et al., 2008).  
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  To test the hypothesis that microglia and the factors they secrete regulate 
developmental neurogenesis in the vertebrate retina, we used independent 
genetic and pharmacological approaches to prevent microglia from colonizing the 
embryonic brain and retina and evaluated the consequences of this on retinal 
neurogenesis. The results show that independent of the method used, when 
microglia fail to colonize the retina, there is a delay in retinal development; retinal 
progenitors remain in the cell cycle at times when they are normally postmitotic, 
and there is a corresponding absence of neuronal differentiation.  
We also included in this study an evaluation of the expression and 
function of the microglia-specific growth factor, Pgrn-a (Craig et al., 2008). At 24 
hours post fertilization (hpf), pgrn-a is expressed throughout the forebrain, but 
beginning about 36hpf pgrn-a expression becomes limited to 
macrophages/microglial precursors in the yolk sac, brain and retina. Knockdown 
of Pgrn-a using morpholino oligonucleotides prevents microglial precursors from 
migrating into the retina. Compared to the genetic mutation or pharmacological 
treatment, which diminish the number of microglia in the retina, depletion of Pgrn-
a results in more severe developmental defects, which likely reflect the sum of 
both the absence of retinal microglia and the depletion of Pgrn-a. Given that 
PGRN governs the cell cycle in peripheral tissues and transformed cells (Ong 
and Bateman, 2003), we evaluated cell cycle kinetics in retinal progenitors 
following Pgrn-a knockdown. Depleting Pgrn-a significantly increases the 
duration of the G2- and M-phases, and this results in an overall increase in the 
total length of the cell cycle. We also found that diminished Pgrn-a results in a 
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significant increase in the expression of genes that promote cell cycle 
progression, and a significant reduction in the expression of genes that promote 
cell cycle exit, demonstrating that Pgrn-a signaling regulates the duration of the 
cell cycle via governing the expression of genes that directly control cell cycle 
progression. From these data, we conclude that the physical presence of 
microglia in the embryonic retina and the presumptive regulatory molecules they 
secrete play fundamental roles in governing developmental neurogenesis. 
Further, we conclude that the microglia-specific molecule, Pgrn-a, functions both 
to recruit microglial precursors to the embryonic CNS and govern cell cycle 
kinetics and neuronal differentiation.  
MATERIALS AND METHODS 
Animals 
Adult AB wild type (WT) and mutant zebrafish (Danio rerio; ZIRC, University of 
Oregon, Eugene, OR, USA) were maintained at 28.5°C on a 14/10-h light/dark 
cycle. Embryos were collected immediately following natural spawns, incubated 
at 28.5°C on a 14/10-h light/dark cycle and staged by hours post fertilization (hpf). 
Homozygous panther mutants (csf1raj4e1/+; AB background) were identified by 
early larval pigment phenotype (Parichy et al., 2000). The Institutional Animal 
Care and Use Committee at the University of Michigan approved all protocols 
and procedures.  
 
PLX5622 Treatment 
PLX5622 is a sister compound of PLX3397, which is a selective small molecule 
inhibitor of colony-stimulating factor 1 receptor (CSF1R) kinase that, in adult 
mammals, promotes apoptosis of microglia (De et al., 2014; Elmore et al., 2014). 
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PLX5622 (1mg/mL stock in DMSO; Plexxikon Inc., www.plexxikon.com) was 
diluted to a 1ug/mL working solution in embryo media (E3). Dechorionated WT 
embryos were treated with 1ug/mL PLX5622 (experimental groups) or E3 
containing 0.01% DMSO (control groups), from 20-72hpf at 28.5°C. At 48hpf, 
72hpf or 8 days post fertilization (dpf), embryos were pulse-labeled with EdU 
(see below), sacrificed and processed for EdU labeling (Click-iT EdU Imaging Kit; 
Invitrogen, Carlsbad, CA, USA) and immunohistochemistry.  
 
Immunohistochemistry (IHC) 
IHC was performed as previously described (Luo et al., 2012). Briefly, embryos 
were fixed overnight in 4% paraformaldehyde (PFA) in 100mM phosphate buffer 
at 4°C, cryoprotected with 20% sucrose in 100mM phosphate buffer, and 
embedded in frozen Tissue-Tek optical cutting temperature (OCT; Sakura 
Finetek USA Inc., Torrance, CA, USA) compound. Sections (10µm thick) were 
mounted on slides, washed, incubated in heat inactivated normal sheep serum 
(NSS), and incubated overnight at 4˚C with primary antibodies. The following day, 
sections were washed and incubated in secondary antibodies.  Nuclei were 
stained with DAPI. Antibodies are listed in Table 2.1. 
 
S-phase labels 
Cells in S-phase of the cell cycle were labeled with either 5-Bromo-
2’deoxyuridine (BrdU; Sigma-Aldrich Corp., St. Louis, MO, USA) or 5-ethynyl-
2’deoxyuridine (EdU; Invitrogen, Carlsbad, CA, USA) as previously described 
(Ochocinska and Hitchcock, 2007; Luo et al., 2012). Briefly, dechorionated 
embryos at 24 and 48hpf were incubated for 20 minutes in ice-cold 10mM BrdU 
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or 1.5mM EdU dissolved in E3 containing 15% DMSO (Westerfield, 2000). 72hpf 
embryos were incubated for 20 minutes in 10mM BrdU or 1.5mM EdU dissolved 
in E3 containing 15% DMSO at room temperature (RT). 8dpf larvae were 
incubated for 20 minutes in 2mM EdU dissolved in E3 at RT. Following the 
labeling step, embryos/larvae were returned to RT E3 for 10 minutes prior to 
fixation. For BrdU staining, sections were incubated in 100°C sodium citrate 
buffer (10mM sodium citrate, 0.05% Tween 20, pH 6.0) for 30 minutes, cooled to 
RT for 60 minutes, and then immunolabeled using standard protocols described 
above.  
In situ hybridization  
Double in situ hybridization (ISH) on retinal sections (Hitchcock and Kakuk-Atkins, 
2004) and whole mount in situ hybridization (wmISH) were performed as 
previously described (Hitchcock and Kakuk-Atkins, 2004; Ochocinska and 
Hitchcock, 2007; Craig et al., 2008; Luo et al., 2012). Sense and antisense 
digoxigenin (DIG)- or fluorescein-labeled riboprobes (Table 2.2) were 
synthesized from full-length cDNA clones for pgrn-a (NM001001949; a gift from 
Dr. Hugh Bennett), fms (NM131672; a gift from Dr. Philippe Herbomel), and 
atoh7 (NM131632; a gift from Dr. Deborah Stenkamp) using in vitro transcription 
(Roche Diagnostic Corp., Indianapolis, IN, USA). Embryos were incubated with 
hybridization solution containing approximately 100ng of probe. For double 
fluorescent in situ hybridization, the fms and pgrn-a probes were hybridized 
simultaneously. 
 
Pgrn-a Knockdown with Morpholino Oligonucleotides (MOs) 
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For Pgrn-a knockdown, two independent antisense MOs (Gene Tools, LLC, 
Philomath, OR, USA), targeting either the 5’UTR (0.25ng/embryo) or the splice 
site between exon 3 and intron 3 (SS, 1ng/embryo) of zebrafish pgrn-a, were 
diluted in 1X Danieau buffer (Nasevicius and Ekker, 2000) containing 2.5% 
phenol red and injected into the yolk of AB WT embryos at the 1-2 cell stage. 5-
base pair mismatch (MM) and standard control (SC) MOs (Gene Tools, LLC, 
Philomath, OR, USA) were used as negative controls. To suppress potential off 
target effects induced by experimental MOs, p53 MO (Gene Tools, LLC, 
Philomath, OR, USA) was co-injected (1.5 fold) to block nonspecific cell death 
(Robu et al., 2007). The MO sequences are listed in Table 2.3.  
 
mRNA Rescue  
The coding sequence of zebrafish (zf) pgrn-a (NM_001001949.2; in pSPORT1 
Vector from H. Bennett Lab) and the pgrn-a paralog, zf pgrn-b (NM_212738.1; in 
pBK-CMV Image Clone from Open Biosystems, GE Dharmacon, Lafayette, CO, 
USA), were PCR amplified starting from the ATG (primer sequences listed in 
Table 2.4), therefore removing the 5’UTR MO recognition sequence, using 
Platinum Taq DNA Polymerase HF (Invitrogen, Carlsbad, CA, USA). cDNAs 
were subcloned into the pGEM-T Easy Vector (Promega, Madison, WI, USA) 
using standard protocols, linearized with SacI-HF (New England Biolabs, Ipswich, 
MA, USA), and capped RNAs were transcribed using the mMESSAGE 
mMACHINE T7 kit (Ambion, Thermo Fisher Scientific, Halethorp, MD, USA). 
Human progranulin (hGRN; GE Healthcare clone ID 3457813 in pCMV-SPORT6) 
and eGFP (pCS2+-EGFP) were linearized with NotI-HF and transcribed with SP6. 
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For rescue experiments, zf pgrn-a (25pg/embryo), zf pgrn-b (25pg/embryo) or 
human progranulin (hGRN; 400pg/embryo) was co-injected with 5’UTR MO 
(.25ng/embryo) at the one cell stage. As a negative control, eGFP mRNA 
(25pg/embryo) was co-injected with the 5’UTR MO (.25ng/embryo). At 72hpf 
Embryos were treated with EdU, sacrificed, and processed for IHC. 
 
Western Blot  
To confirm knockdown of Pgrn-a, Western blotting was performed as previously 
described (Gramage et al., 2015). Briefly, for each condition, protein was isolated 
from 50 embryo heads and separated by gel electrophoresis. Proteins were 
transferred to polyvinylidene difluoride (PVDF) membranes (GenHunter Corp., 
Nashville, TN, USA) and incubated with rabbit anti-Pgrn antibodies (1:2000, a gift 
from Jen Leih Wu, see Li et al., 2010). Immunolabeled proteins were detected 
using enhanced chemiluminescence assay (ECL detection system, Amersham 
Biosciences, Arlington Heights, IL, USA). Anti-actin (1:1000, Calbiochem, EMD 
Millipore, Billerica, MA, USA) was used as a loading control.  
 
PCR 
To verify SS-targeting MOs altered processing of pgrn-a pre-mRNA, PCR was 
performed on RNA isolated from SS morphant and uninjected control embryos at 
48hpf. cDNA was reverse transcribed using the SuperScript kit (Invitrogen, 
Carlsbad, CA, USA). Primers flanking the SS MO target sequence (F: 
AGAATGTTGTGAGGACCATC and R: CTGTGCTACTGGACAGCAG) were 
used to amplify the pgrn-a locus. PCR products were separated by gel 
electrophoresis, purified and sequenced.  
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Cell Cycle Kinetics 
Mitotic Index 
The proportion of cells in the M-phase of the cell cycle was determined for 
embryos at 28hpf Retinal sections were immunolabeled with anti-phosphorylated 
histone H3 (pH3), marking cells in the M-phase, and the number of M-phase cells 
as a function of retinal area (um2) was calculated. The spatial pattern of pH3 
labeled cells was also assessed.  
Percent Labeled Mitosis  
The length of the G2-phase of the cell cycle was determined using the percent 
labeled mitosis technique (Quastler and Sherman, 1959; Luo et al., 2012). 
Embryos at 28hpf were incubated in BrdU for 20 minutes to label all cells in the 
S-phase of the cell cycle. Starting 10 minutes after BrdU exposure, embryos 
were collected at 30 minutes intervals through 35hpf, sectioned and 
immunolabeled with anti-pH3 and anti-BrdU antibodies. The proportion of double-
labeled retinal cells ((pH3+BrdU+)/(pH3+)) was plotted as a function of time 
following BrdU exposure.  
Pulse-Chase-Pulse  
To determine the relative length of S-phase (Ts) and estimate the total cell cycle 
length (Tc), a pulse chase pulse method was used as previously described 
(Rachel et al., 2002). At 26hpf, embryos were incubated in 10mM BrdU dissolved 
in E3 containing 15% DMSO for 20 minutes on ice, rinsed in E3 at RT, incubated 
in 10mM thymidine at 28.5°C for 20 minutes (Otteson et al., 2001), washed in E3 
for 1hr 40 minutes at 28.5°C and incubated in 1.5mM EdU dissolved in E3 
containing 15% DMSO for 20 minutes on ice. Embryos were then rinsed for an 
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additional 10 minutes, sacrificed and processed sequentially to label BrdU and 
EdU. Nuclei were counterstained with DAPI. For each embryo, an optical section 
from the middle of a z-stack taken of one central retina section was selected and 
cells labeled with BrdU (nBrdU), EdU (nEdU) and DAPI (nDAPI) were counted. 
The length of the S-phase and total length of the cell cycle were determined 
using the following formulae, Ts=2/(nBrdU+/ntotal EdU+) and Tc=Ts/(nEdU+/nDAPI+), 
respectively.  
 
Reverse transcriptase quantitative real-time PCR (qRT-PCR) for cyclins (B, 
D, and E) and cyclin-dependent kinase inhibitors (p27kip and p57kip) 
To determnine the expression levels of genes that regulate cell cycle, qRT-PCR 
was performed as previously described (Taylor et al., 2015). For each condition, 
three biological replicates of 50 embryo heads were collected. Total RNA was 
isolated from pooled heads using the Aurum Total RNA Mini Kit (Bio-Rad 
Laboratories Inc., Hercules, CA, USA). cDNA was synthesized using the 
QuantiTect Reverse Transcription kit (Qiagen, Hilden, Germany). Three technical 
replicates of each biological replicate were run in a Bio-Rad CFX384 Touch Real 
Time PCR Detection System using 6ng cDNA and Bio-Rad IQ SYBR Green 
Supermix. Primers are listed in Table 2.5. Gene expression was calculated using 
Bio-Rad CFX Manager Software and normalized to β-actin.    
 
Statistical Analysis 
Quantitative data was represented by means and standard deviations. To 
calculate statistical significance, a one-way ANOVA or Student’s t-test was used 
(GraphPad Prism Software, La Jolla, CA, USA). A p-value ≤ 0.05 was considered 
significant, unless otherwise noted.  
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Imaging 
All sectioned material was sealed with glass coverslips and mounting media 
(Electron Microscopy Sciences, Hatfield, PA, USA). Fluorescence images were 
captured using a Leica TCS SP5 confocal microscope (Leica, Wetzler, Germany). 
Bright field images were captured using either a Leica DM6000 CFS or Leica 
M165FC microscope (Leica, Wetzler, Germany).  
RESULTS 
Absence of microglia in the retina alters retinal neurogenesis 
Compared to warm blooded vertebrates, retinal morphogenesis in 
zebrafish is very rapid. By 24hpf, eyecups have formed from the anterior neural 
plate, and the retina is a layer of proliferating neuroepithelial cells (Schmitt and 
Dowling, 1994; 1996; Li et al., 2000). At approximately 28hpf, neuronal 
differentiation begins and ganglion cells are the first to exit the cell cycle in a 
small ventronasal patch (Hu and Easter, 1999). Neuronal differentiation and 
lamination progress sequentially from the ventronasal patch in circumferential 
waves that move dorsally, then temporally (Schmitt and Dowling, 1996; 1999; 
Hitchcock and Raymond, 2004). By 72hpf, the initial phase of neurogenesis is 
largely complete, and the retina is fully laminated and functional (Easter and 
Nicola, 1996). Beyond 72hpf and into adulthood, the retina continues to grow by 
expansion and the addition of new neurons from the ciliary marginal zone (CMZ; 
Hitchcock et al., 2004; Raymond et al., 2006).  
 In zebrafish, macrophages/microglial precursors migrate from the yolk sac 
into head mesenchyme between 22-40hpf, colonize neuroepithelial tissues, 
including the retina, between 30-48hpf, then undergo a phenotypic 
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transformation around 60hpf to adopt their final microglial state (Herbomel et al., 
1999; Herbomel, 2001). The colony-stimulating factor 1 receptor (Csf1r) is a 
tyrosine kinase transmembrane receptor expressed by the macrophage lineage, 
and therefore microglia. Migration of microglial precursors to the brain and retina 
is dependent on Csf1r (Pixley, 2012). Panther mutants lack a functional fms gene, 
which encodes the Csf1r (Parichy et al., 2000), and in panther embryos, 
macrophages fail to migrate from the yolk sac into the embryonic brain and retina 
(Herbomel et al., 2001; Figure 2.1 A). 
To determine if the absence of microglia in panther mutants alters retinal 
neurogenesis, qualitative and quantitative meaures of cell proliferation, neuronal 
differentiation, and retinal size were compared in retinas of WT and panther 
embryos at 48 and 72hpf (Figure 2.2). In WT embryos at 48hpf, EdU-positive 
retinal progenitors are largely confined to the retinal periphery and the nascent 
outer nuclear layer (onl; Figure 2.2 A-C). In the central retina, the absence of 
EdU reflects exit from the cell cycle prior to EdU exposure by neurons in the 
inner nuclear and ganglion cell layers (inl and gcl, respectively) (Figure 2.2 A-C). 
Nuclear staining with DAPI reveals the presence of immature laminae, and 
markers of mature neurons label a small number of differentiated ganglion cells 
(Figure 2.2 A), amacrine cells (Figure 2.2 B), and photoreceptors (confinded to 
the ventral patch; Figure 2.2 C). At 48hpf, the retinas of panther embryos are 
significantly smaller than WT retinas (Figure 2.2 M). In marked contrast to WT 
embryos, EdU-positive progenitors are present throughout the panther retinas, 
and there is an absence of both lamination and neuronal differentiation (Figure 
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2.2 D-F, N). In WT retinas at 72hpf, EdU-positive progenitors are few in number 
(Figure 2.2 N) and restricted to the CMZ (brackets, Figure 2.2 G-I). Further, the 
retina is fully laminated, and, reflecting its functional state, mature neurons are 
present throughout each of the retinal layers (Figure 2.2 G-I). In panther retinas 
at 72hpf, EdU-labeled progenitors are much more numerous than in WT retinas 
and are scattered throughout both the inl and onl (Figure 2.2 J-L, N). In addition, 
lamination is incomplete, and there is an overall paucity of differentiated neurons 
(Figure 2.2 J-L). Despite the overall lack of cell cycle exit and neuronal 
differentiation, at 72hpf retinal size is similar in WT and panther larvae (Figure 
2.2 M). Collectively, these data show that the absence of retinal microglia results 
in a significant temporal delay in retinal neurogenesis. Progenitors fail to exit the 
cell cycle at the appropriate developmental time, and among postmitotic neurons 
there is diminished differentiation.  
In panther mutants, the temporal progression of retinal development from 
48 to 72hpf is delayed, but the spatial pattern of neurogenesis appears largely 
normal. This suggests that beyond 72hpf retinal development in panther mutants 
might eventually approximate WT. To determine if panther retinas recover from 
the initial developmental delay, retinal size, neuronal differentiation and the 
pattern of cell proliferation were compared in WT and panther larvae at 8 days 
post fertilization (dpf; Figure 2.3 A-C). At this time point, both the laminar 
structure and markers of differentiated photoreceptors and amacrine cells appear 
qualitatively equivalent, and there is no difference in the size of the retinas 
(Figure 2.3 B). Qualitative observations suggest that, compared to WT, the 
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retinas of panther mutants have fewer EdU-positive cells in the CMZ (Figure 2.3 
A), because exposure to EdU for the same duration as WT did not label cells in 
the CMZ (Figure 2.3 A). However, subsequent staining with antibodies against 
PCNA revealed mitotically active cells in the CMZ (Figure 2.3 A). Notably, the 
paucity of microglia in panther retinas persists (Figure 2.3 C).  
 
Pharmacologically blocking macrophage migration into the CNS 
phenocopies panther mutants  
 As a second test of our hypothesis, a pharmacologic method was used to 
block the migration of macrophages/microglial precursors into the brain and 
retina. WT embryos were treated with PLX5622, a selective small molecule 
inhibitor of CSF1R, from 20hpf, prior to the onset of macrophage migration from 
the yolk sac, until 72hpf. Control embryos were treated with vehicle solution only. 
Though not as complete as the genetic lesion, treatment with PLX5622 
significantly arrests the migration of macrophages/microglial precursors into the 
retina (Figure 2.1 B), and this recapitulates the results observed for the panther 
mutants. At 48 and 72hpf, control embryos (Figure 2.4 A-C and G-I, respectively) 
closely approximate WT retinas at these ages (see Figure 2.2 A-C and G-I, 
repectively).  Although, treatment with E3 and DMSO (vehicle solution) alone 
does not alter the normal developmental patterns, it does cause a slight temporal 
delay, as evidenced by the lack of HPC1 labeling at 48hpf (Figure 2.4 B) and the 
slight expansion of the CMZ at 72hpf (Figure 2.4 G-I). Nonetheless, in embryos 
treated with PLX5622, at both 48 and 72hpf, there is an increase in the number 
of EdU-labeled progenitors (Figure 2.4 D-F, J-L, M, N), laminae are either absent 
or immature, and there is a paucity of mature neurons. Similar to panther 
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mutants, at 48hpf PLX5622-treated retinas are significantly smaller than control 
retinas, and this, too recovers by 72hpf (Figure 2.4 M).  
Unlike in panther mutants, pharmacological treatment can be temporally 
controlled. Therefore, for some larvae, PLX5622 treatment was stopped at 72hpf 
to determine if the retina recovers from the initial developmental delay and 
whether or not microglia recolonize the retina. At 8dpf, 5 days after PLX5622 
treatment ended, the retinal size, laminar organization, neuronal differentiation 
and pattern of cell proliferation in experimental retinas were restored to control 
levels. (Figure 2.3 D+E). Interestingly, unlike panther mutants, at 8dpf, there was 
no significant difference in the number of retinal microglia in control and 
PLX5622-treated larvae (Figure 2.3 F).  
 
Developmental expression of pgrn-a 
 We identified pgrn-a in the zebrafish retina through an unbiased screen for 
genes modulated during neuronal regeneration (see 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE13999), and determined 
that in the adult retina pgrn-a is expressed exclusively by microglia (Craig et al., 
2008). Based on these data and the observation that, in vitro, Pgrn is a 
chemoattractant to microglia (Pickford et al., 2011), we hypothesized that Pgrn-a 
plays a fundamental role in developmental neurogenesis, and may also regulate 
the migration of microglial precursors into neuroepithelial tissues. We first 
established the developmental cellular pattern of pgrn-a expression using in situ 
hybridization (Figure 2.5 A-D, F-I). At 24hpf, pgrn-a is expressed throughout the 
forebrain and retina (Figure 2.5 A+F). Between 24 and 48hpf, pgrn-a expression 
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becomes restricted to putative macrophages/microglial precursors in the yolk sac, 
forebrain and retina (arrowheads, Figure 2.5 B, G-H), a pattern that persists 
through 72hpf (Figure 2.5 C-D, I). While at 72hpf it appears in retinal sections 
there is transcript expression in the CMZ (Figure 2.5 I), there is no evidence for 
this following whole mount ISH (Figure 2.5 C-D), and we infer that in sections this 
apparent labeling is spurious. There are no antibodies that detect zebrafish Pgrn-
a in tissue sections, however, Western blot analysis showed that Pgrn-a is 
present at 24hpf (Figure 2.5 E), suggesting that the protein is reliably expressed 
when transcript is present. To confirm that pgrn-a expressing cells in the 
embryonic retina are microglia, pgrn-a in situ hybridizations were combined with 
immunstaining using the microglial markers, L-plastin (Herbomel and Levraud, 
2005) and 4C4 (Raymond et al., 2006), and double in situ hybridizations using a 
fms probe, which encodes the CSF1R. In the retina, all cells that express pgrn-a 
(Figure 2.5 J+L) are co-labeled with antibodies to L-plastin (Figure 2.5 K) or 4C4 
(Figure 2.5 M) and co-express fms (Figure 2.5 N-Q).  
 
Knockdown of Pgrn-a results in a paucity of microglia and diminished 
neuronal differentiation  
 Two independent antisense MOs were used to block Pgrn-a synthesis. 
The ability to knockdown Pgrn-a with the 5’UTR-targeting MO was confirmed with 
Western blot analysis (Figure 2.6 A-B). Diagnostic PCR showed that the SS-
targeting MO resulted in intron retention and a premature stop codon (Figure 2.7). 
There were no qualitative changes in the appearance of morphant retinas 
between 48 and 72hpf, so only data from only 72hpf embryos are described here. 
At 72hpf, the overall body size and shape of control embryos (Figure 2.6 D-F) 
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and pgrn-a morphants (Figure 2.6 G-H) were comparable to uninjected WT 
embryos (Figure 2.6 C). Although, compared to controls, pgrn-a morphants have 
markedly small forebrains and microphthalmia.  
To determine the functional consequences of Pgrn-a knockdown, 
qualitative and quantitative measures of cell proliferation, neuronal differentiation 
and retinal size were compared between control and experimental groups. As for 
both the panther mutants and PLX5622-treated embyros, the number of retinal 
microglia was significantly decreased in pgrn-a morphants compared to controls 
(Figure 2.1 C). Regardless of the MO used, all control embryos (Figure 2.8 A-L) 
appear WT (Figure 2.2 G-I). In contrast, blocking the translation of Pgrn-a results 
in a retinal phenotype similar to, but more severe than!that observed in either the 
panther mutants or PLX5622-treated embryos. Compared to controls (Figure 2.8 
A-L), retinas in morphants contain significantly more EdU-positive retinal 
progenitors and completely lack laminae and differentiated neurons (Figure 2.8 
M-R). The microphthalmia observed in the whole mount embryos (Figure 2.8 A-
F) was readily observable in retinal sections (Figure 2.8 S). As was also evident 
in the whole embryos, the alterations in the retinas of the 5’UTR morphants are 
slightly more severe than the SS morphants. We interpret this to be a dose-
dependent effect resulting from the SS MO targeting zygotic transcripts only, 
whereas the 5’UTR MO targets both maternal and zygotic transcripts (Cadieux et 
al., 2005; Bill et al., 2009). All subsequent data presented here use the 5’UTR-
targeting MO to knockdown Pgrn-a.  
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MO concentrations decrease with each cell division, and, as a result, MO-
dependent translation inhibition lasts approximately 3-4 dpf (Nasevicius and 
Ekker, 2000). Therefore, we also evaluated the potential recovery of retinal 
development in pgrn-a morphants. When morphants are allowed to survive to 8 
dpf, Pgrn-a synthesis recovers and cellular differentiation and the 
cytoarchitecture of the retina follow normal developmental patterns (Figure 2.9 A), 
however, the retinal size does not recover to control values (Figure 2.9 B). So too, 
the number of microglia remains significantly below control values (Figure 2.9 C).  
 
Neurogenic competence and cell death is not altered in morphants  
 Morpholino oligonucleotides have the potential to create spurious results 
from off-target effects (Eisen and Smith, 2008). As a first of several approaches 
to assess this, we determined whether or not the retinal changes observed here 
were due to a non-specific developmental delay. atoh7 is required to initiate 
neurogenesis and serves as an indicator of the onset of neurogenic competence 
(Masai et al., 2000; Kay, 2005). Pgrn-a knockdown does not alter the timing or 
spatial restriction of the initial atoh7 expression (Figure 2.10 A-C), indicating that 
the changes in retinal development are not a consequence of a simple 
developmental delay. Cell death is another potential off target affect. In embryos 
at 24 and 48hpf, counts of pyknotic nuclei labeled with acridine orange and 
apoptotic cells marked by terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) show no significant differences between control and 
experimental embryos (Figure 2.10 D), indicating the cell death cannot account 
for the changes in retinal development. 
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Co-injection of zf pgrn-a/b or hGRN mRNA rescues Pgrn-a knockdown 
 To validate the specificity of the Pgrn-a knockdown, mRNA encoding egfp, 
zf pgrn-a, zf pgrn-b, or hGRN was co-injected with the 5’UTR MO. To determine 
if exogenous mRNA rescued the knockdown phenotype, comparisons were 
made between embryos that were uninjected (Figure 2.11 A-C), injected with 
5’UTR MO alone (Figure 2.11 D-F), and co-injected with 5’UTR MO and one of 
the mRNA constructs (Figure 2.11 G-O). As a control for the mRNA injections, 
the 5’UTR MO and egfp mRNA were co-injected, and this failed to rescue the 
developmental defects resulting from Pgrn-a knockdown (data not shown; Figure 
2.11 P-R). In contrast, both zebrafish pgrn paralogs and the human pgrn mRNA 
rescued the morpholino-induced developmental defects in retinal growth, cell 
proliferation and neuronal maturation. In these larvae, EdU-labeled retinal 
progenitors were present only in the CMZ, retinal laminae were fully formed, and 
retinal size was equal to controls (Figure 2.11 G-O, P+Q). These data validate 
the specificity of the morpholinos targeted to pgrn-a, and demonstrate that Pgrn-
a regulates both cell proliferation and neuronal differentiation. Finally, these 
experiments highlight the conserved function of progranulin protein between fish 
and humans. Interestingly, co-injecting mRNA only partially rescues the migration 
of macrophages/microglial precursors into the retina (Figure 2.11 R). In embryos 
co-injected with Pgrn mRNA, the total number of retinal microglia is significantly 
increased compared to morphants; however, there were still significantly fewer 
retinal microglia when compared to uninjected controls (Figure 2.11 R).  
 
Pgrn-a knockdown alters cell cycle kinetics  
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 In morphants, the persistence of retinal progenitors at a stage when these 
cells normally exit the cell cycle, suggests that Pgrn-a functions to promote 
progression through the cell cycle. Therefore, we determined the consequences 
of Pgrn-a knockdown on cell cycle kinetics using three approaches to measure 
the duration of individual components of the cell cycle and overall length of the 
cell cycle. First, the mitotic index was assayed at 28hpf. Sections through central 
retina were immunolabeled with anti-pH3, a marker of cells in M-phase and the 
proportion of pH3-positive cells was determined. In the retina, cells divide at the 
apical surface of the neuroepithelium (Das et al., 2003; Baye and Link, 2007). 
Following Pgrn-a knockdown, the location of pH3-positive cells was similar in 
morphants and controls (Figure 2.12 A), indicating that the fundamental 
polarization of the neuroepithelium and inter kinetic nuclear migration is 
unchanged by knockdown of Pgrn-a (see Baye and Link, 2007). In contrast, the 
number and proportion of M-phase cells was significantly less in the morphant 
retinas (Figure 2.12 B). Similarly, the mitotic index in both panther and PLX5622 
treated retinas was also significantly less than in controls (Figure 2.13).  
 Second, the length of the G2-phase of the cell cycle was determined using 
the Percent Labeled Mitosis method (Quastler and Sherman, 1959). This assay 
measures the interval between the S-phase, when cells can be labeled with BrdU, 
and when BrdU-positive cells undergo mitosis and become positive for pH3. The 
resulting curve represents the percentage of BrdU-labeled cells that are co-
labeled with pH3 at each of the time points sampeled. In control embryos, the 
percentage of double-labeled nuclei increases sigmoidally over time (Figure 2.12 
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C; see Luo et al., 2012). For control groups, the curves plateau at 100% at about 
2.5 hours, thereby defining the duration of the G2-phase. In contrast, in Pgrn-a 
morphants, the curve is shifted to the right. There were significantly fewer 
double-labeled cells at 60, 90, 120, 150, 300, and 330 minutes, indicating a G2-
phase of about 3 hrs. Additionally, whereas the control curves begin to return to 
zero as BrdU-positive cells exit the M-phase and migrate away from the apical 
surface of the retina (Baye and Link, 2007), morphant retinal progenitors appear 
delayed in M. These cells eventually exit the M-phase and re-enter the cell cycle, 
because the number of progenitors does accumulate over time (cf. Figure 2.8 P-
R, Figure 2.12 A). Therefore, these data show that knockdown of Pgrn-a results 
in a slower G2-phase and a prolongation of the M-phase.  
Third, a pulse chase pulse paradigm was used to determine the relative 
length of S-phase (TS) and estimate the total cell cycle length (TC) (Rachel et al., 
2002). This analysis showed the duration of the S-phase (TS) is 6 hours (hrs) and 
is invariant in morphants and controls (Figure 2.12 D). The total length of the cell 
cycle (TC) in uninjected controls is approximately 10hrs (Figure 2.12 E), which 
recapitulates previous findings in WT embryos (see Nawrocki, 1985; Li et al., 
2000). However, the TC in morphant retinas is approximately 14hrs, which is 
significantly greater compared to controls (Figure 2.12 E).  These and the 
aforementioned PLM data reveal that the G1-phase is also longer in morphants 
(~5hrs) than in controls (~1.5hrs).  
 To gain insight into the proximal molecular mechanisms that underlie 
Pgrn-a control of the cell cycle, qRTPCR was performed at 30 and 72hpf to 
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measure the expression levels of genes that promote cell cycle exit, e.g., p27kip 
and p57kip2 and genes that promote cell cycle progression, e.g., cyclin B, D1 
and E. Compared to controls, at both 30 and 72hpf the expression level of p27kip 
is significantly lower in morphants (Figure 2.12 F), whereas at 72hpf the 
expression levels of cyclinB and cyclinD are significantly higher (Figure 2.12 G).  
 
DISCUSSION  
 Historically, microglia were characterized as resident CNS macrophages, 
the primary responders to brain injury or disease that cleared cellular debris and 
released factors as part of the immune response (Peri and Nüsslein-Volhard, 
2008; Saijo and Glass, 2011). However, this narrow view is widening as evidence 
of the neurogenic role microglia play in both the developing and 
adult/regenerating brain increases. In vitro studies have shown microglia regulate 
aspects of neural progenitor proliferation, differentiation and survival (Review by 
Su et al., 2014; Sato, 2015). In vivo, in birds, microglia are required for the injury-
induced proliferative response of Muller glia-derived neural progenitor cells in the 
retina (Fischer et al., 2014). In mice, microglia regulate the size of the neural 
progenitor pool in the embryonic subventricular zone (SVZ) (Cunningham et al., 
2013), and promote neural progenitor survival and migration in the adult SVZ 
(Ribeiro Xavier et al., 2015). The data reported here adds to this growing body of 
literature by illustrating the fundamental role microglia play in governing early 
retinal neurogenesis. 
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In this study we utilized independent experimental approaches that 
blocked macrophages/microglial precursors from colonizing neuroepithelial 
tissues to determine whether the presence of microglia within the parenchyma 
governs developmental neurogenesis in the zebrafish retina. The results showed 
that when microglia fail to colonize the retina, neurogenesis is significantly 
altered. Retinal progenitors do not exit the cell cycle at the appropriate 
developmental time, and both neuronal differentiation and early retinal growth is 
delayed. Further, either excluding microglia from colonizing the retina or knocking 
down the microglia-specific protein, Pgrn-a, results in a significant lengthening 
the cell cycle, and this serves as the mechanistic explanation for the delay in 
retinal development when microglia and the molecules they release are excluded 
from the retina. Collectively, these data demonstrate that the microglia that 
colonize the embryonic brain and retina play a fundamental role in governing 
early neurogenic events and serve as cellular components that regulate the 
brain’s intrinsic timing of the cell cycle.  
Members of the zebrafish community have recently expressed concerns 
regarding the use of MOs as experimental tools (Schulte-Merker and Stainier, 
2014), and some have declared data based on MOs untrustworthy (Kok et al., 
2015). Nonetheless, we are confident in the data presented here that are based 
on MO-induced knockdown of Pgrn-a. First, we used two independent MOs that 
targeted different regions of pgrn-a, and each MO produced essentially identical 
results. Second, we confirmed specific knockdown of Pgrn-a protein by Western 
blot analysis. Third, we used low, minimum doses of MOs: 0.25ng and 1ng for 
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the 5’UTR and SS MO, respectively. Fourth, we co-injected each experimental 
MO with a p53-targeting MO to suppress p53 activity and minimize off target/non-
specific effects, including ectopic cell death. Fifth, we characterized the retinal 
phenotype in morphants at 72hpf, a time at which the MO-induced knockdown 
and the concentration of MOs in individual cells is nearing its effective limit 
(unpublished observations; Bill et al., 2009). Sixth, co-injecting Pgrn mRNA 
uniformly rescued the morphant phenotype, which validates the specificity of the 
MOs and the relationship between Pgrn-a knockdown and the retinal phenotype. 
Finally, the morphant phenotype was largely recapitulated by simply excluding 
microglia, and the presumptive Pgrn-a they release, from the embryonic retina. 
Together, these observations support the data presented here and suggest that, 
when used at limiting doses and rigorously controlled, MOs have a place in the 
repertoire of zebrafish biologists.   
 Though the ontogeny of microglia was debated for many years (Reviewed 
in Cuadros and Navascués, 2001; Ginhoux and Prinz, 2015), it is now 
established in fish (Herbomel, 2001), birds (Cuadros et al., 1993), and rodents 
(Ginhoux et al., 2010) that embryonic microglia originate as primitive yolk sac 
macrophages. The migration of macrophages/microglial precursors into the 
developing CNS is also highly conserved across vertebrate species (fish: 
Herbomel, 2001; rodents: Swinnen et al., 2013; humans: Verney et al., 2010). 
After colonizing the parenchyma of the embryonic brain, early macrophages 
concurrently undergo a phenotypic transformation to become microglia 
(Herbomel, 2001). Although the mechanisms that regulate microglial migration 
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and maturation are not completely understood, these processes depend on 
multiple factors and are critical for normal CNS development and function 
(Reviewed in Nayak et al., 2014; Prinz and Priller, 2014).   
 In vertebrates, microglia colonize the embryonic CNS and govern early 
neurogenic events. When microglial precursors fail to colonize the CNS, 
developmental neurogenesis is aberrant. Csf1r knockout mice (Csf1r-/-) 
completely lack CNS microglia (Ginhoux et al., 2010; Erblich et al., 2011) and 
have multiple developmental brain abnormalities, including small brains, 
increased neuronal density and decreased cortical thickness (Nandi et al., 2012). 
Csf1r-/- mice do not live beyond one month of age (Dai et al., 2004). Further, in 
the neocortex of Csf1r-/- mice, the number of neural progenitors and overall 
cellular proliferation is increased, while neuronal differentiation is decreased 
(Nandi et al., 2012). Our data shows that, similar to Csf1r-/- mice, genetically or 
pharmacologically blocking Csf1r function during zebrafish embryogenesis 
causes neurodevelopmental defects within the retina. Both panther mutant and 
PLX5622-treated embryonic retinas lack microglia and have a significantly 
increased number of proliferating retinal progenitors, which corresponds to an 
absence of neuronal differentiation at the time when initial retinal development is 
normally complete. Therefore, the presence of microglia in the embryonic brain 
and retina is required for normal developmental neurogenesis. Neither the 
panther mutants nor Pgrn-a morphants recover WT levels of retinal microglia by 
8dpf, though in both models, the retinas were fully differentiated at this time. 
These results suggest there is an early critical window of retinal neurogenesis 
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that depends on the presence of microglia and/or Pgrn-a, and outside this 
window other cellular and/or molecular mechanisms are sufficient to drive retinal 
neurogenesis to completion. 
 There are numerous factors, in addition to Csf1r, that regulate microglial 
migration into the developing CNS. In zebrafish, cell autonomous factors, such 
as the Leucine/Arginine transporter, slc7a7 (Rossi et al., 2015), phosphate 
exporter XPR1 orthologue, xpr1b (Meireles et al., 2014), and noncanonical NOD-
like receptor, nlrc3-like (Shiau et al., 2013), are required for primitive macrophage 
migration to and colonization of embryonic neuroepithelial tissues. Zebrafish 
slc7a7, xpr1b, and nlrc3-like mutants all lack microglia (Shiau et al., 2013; 
Meireles et al., 2014; Rossi et al., 2015), though the embryonic retinal and brain 
phenotypes among these mutants remain to be determined. Non-cell 
autonomous factors produced by neuroepithelial tissues, such as cell death 
signals and chemokines, also promote macrophage chemotaxis during 
development of the brain and retina (Reviewed in Polazzi and Contestabile, 
2002; Schwarz and Bilbo, 2013). Based on our findings, Pgrn-a can be added to 
the list of factors that originate in neural progenitors and are required for 
microglial colonization of the developing zebrafish CNS.   
Progranulin is a soluble growth factor that has multiple functions in 
developing and adult vertebrates. In vitro, PGRN promotes migration and 
invasiveness of transformed cells (Tangkeangsirisin and Serrero, 2004; Monami 
et al., 2006; Swamydas et al., 2011; Dong et al., 2015), stimulates proliferation 
and migration of endothelial and fibroblast cells (Bateman and Bennett, 2009), 
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and acts as a chemoattractant to microglia (Pickford et al., 2011). In vivo, 
application of PGRN to a cutaneous wound results in an increase in macrophage, 
neutrophil, and blood vessel accumulation in the wound (He et al., 2003). In 
humans, macrophage infiltration into adipose tissues correlates with circulating 
PGRN, further suggesting PGRN acts as a macrophage chemotactic factor 
(Youn et al., 2009). Our data are the first to demonstrate Pgrn-a regulates the 
migration of microglial precursors into neuroepithelial tissues and therefore acts 
as a chemoattractant to microglia in vivo. We hypothesize that during early 
zebrafish embryogenesis, the developing forebrain serves as a source of Pgrn-a, 
thereby establishing a morphogenic gradient between the brain and yolk sac. 
Microglial precursors migrate up the Pgrn-a gradient. Consistent with our 
hypothesis, depleting of Pgrn-a significantly decreases the number of microglia 
that invade the retina. In rescue experiments, exogenous pgrn-a (or pgrn-b) is 
ubiquitously expressed in every cell. While this restores the function of Pgrn-a 
during retinal neurogenesis, there is no discrete source of Pgrn-a protein that is 
sufficient to fully rescue the failure of microglia to invade the retina. Together, 
these data suggest that, similar to in vitro results (Pickford et al., 2011), in vivo, 
Pgrn-a can act as a chemoattractant and direct microglial migration into 
neuroepthilial tissues.  
 In zebrafish, Pgrn-a is a growth factor that governs both migration of 
microglial precursors into the embryonic brain and cell cycle kinetics among 
neural progenitors. Progranulin was first identified as a novel autocrine epithelial 
cell growth factor in peripheral tissues (Review by Bateman and Bennett, 1998). 
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Subsequent studies have shown that in humans Progranulin is involved in both 
neurodegeneration and glioblastoma (De Muynck and Van Damme, 2011). 
PGRN was first identified as a mitogen in the tumorigenic PC cell line (Zhou et al., 
1993). Later studies established that the level of PGRN expression is directly 
proportional to proliferation rate of cells in vitro and tumorigenicity in vivo, such 
that increased PGRN levels accelerates cell division (He and Bateman, 1999) 
and decreased PGRN levels attenuates tumor growth (Zhang and Serrero, 1998). 
Acting as both a competence and progression factor, PGRN promotes mitosis in 
embryonic and adult epithelial cells by stimulating classic growth factor signal 
transduction cascades, such as mitogen-activated protein kinase 
(MAPK)/extracellular-signal-related kinase (ERK) and phosphatidylinositol 3-
kinase (PI3K) pathways (Reviewed by Ong and Bateman, 2003; Bateman and 
Bennett, 2009). Modulation of PGRN levels within the CNS appears to similarly 
effect cell cycle activity. Our data demonstrates Pgrn-a promotes mitosis in 
retinal progenitors in vivo. Pgrn-a knockdown results in a significant lengthening 
of the cell cycle in retinal progenitors. Further, when Pgrn-a is reduced, the 
number of cells in the retina undergoing mitosis and terminally differentiating is 
significantly decreased. From the mitotic index data determined for each of the 
three models studied here, we conclude that the changes in cell cycle kinetics 
observed among the retinal progenitors in morphants are likely present in 
panther mutants and embryos treated with PLX5622. In Pgrn-a morphants, 
mitotically active cells take longer to transit G1 and G2 and undergo mitosis. 
Overall, these data indicate that in retinal progenitors Pgrn-a governs the 
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duration of the G1-, G2- and M-phases of the cell cycle. Therefore, Pgrn-a 
normally functions to promote cell cycle progression and neuronal differentiation 
in the developing retina. This illustrates that Pgrn-a functions similarly in 
peripheral tissues and the CNS by driving cells through the cell cycle. The cell 
cycle data were analyzed at a stage when all neural progenitors express pgrn-a, 
and suggest that among these cells Pgrn-a may function as either an autocrine 
or paracrine growth factor. In contrast, as 72hpf, when Pgrn-a expression can be 
ascribed solely to microglia, the changes in cell cycle kinetics likely reflects the 
consequence of both the absence of Pgrn-a and microglia, including other 
molecules released by microglia that may regulate cell cycle kinetics. Together, 
our findings indicate that, although relatively few in number, microglia regulate 
neurogenesis in the developing retina, and that among retinal progenitors, factors 
expressed or secreted by microglia, including the growth factor Pgrn-a, function 
to promote progression through the cell cycle and cell cycle exit. 
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Figure 2.1: Quantification of retinal microglia at 72hpf. (A) Histogram showing the 
number of microglia (4C4+ cells) in the retinas of wild type (WT; 63.8 ± 18.7 cells; n=6) 
and panther mutants (1.0 ± 1.0 cells; n=11) at 72hpf; ***p≤0.001. (B) Histogram showing 
the total number microglia in DMSO-treated control retinas (45.2 ± 7.7; n=6) and retinas 
treated with PLX5622 (10.3 ± 8.6; n=14) at 72hpf; ***p≤0.001. (C) Histogram showing 
the number of microglia in uninjected (UI; 55.4 ± 21.5 cells; n=20), 5’UTR mismatch 
morpholino injected (5’UTR MM; 43.4 ± 4.6 cells; n=8), and Pgrn-a morphant (5’UTR 
MO; 4.4 ± 3.4 cells; n=11) retinas at 72hpf; ***p≤0.001. Data are represented as mean; 
error bars reperesent the standard deviation. 
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Figure 2.2: Developmental neurogenesis is altered in the retinas of panther mutant 
embryos. (A-L) Transverse sections through central retina of wild type (WT; A-C; G-I) 
and homozygous panther mutant (D-F; J-L) embryos at 48 and 72hpf, respectively. 
Sections are immunolabeled with cell-specific antibody markers (cyan) for ganglion cells 
(Zn5, top row), amacrine cells (HCP1, middle row), and red-green double cone 
photoreceptor cells (Zpr1, bottom row), EdU (fusia), and DAPI (gray). (M) Histogram 
showing relative retinal area of WT (10938.2 ± 959.6 µm2; n=7) and panther mutant 
(5879.2 ± 983.0 µm2; n=15) retinas at 48hpf (***p≤0.001), and WT (13498.4 ± 2427.9 
µm2; n=5) and panther mutant (11713.7 ± 2715.9 µm2; n=22) retinas at 72hpf. (N) 
Histogram showing the percent of the retina labeled with EdU in WT (43.2 ± 2.2%; n=15) 
and panther mutant (80.7 ± 5.5%; n=7) retinas at 48hpf, and WT (7.0 ± 2.0 %; n=5) and 
panther mutant (35.2 ± 11.1%; n=22) retinas at 72hpf; ***p≤0.001. Data are represented 
as mean; error bars reperesent the standard deviation. Outer nuclear layer (ONL); inner 
nuclear layer (INL); ganglion cell layer (GCL); ciliary marginal zone (CMZ, brackets). 
Scale bar equals 50µm. 
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Figure 2.3: Retinal phenotype of 8dpf panther mutant and PLX5622-treated 
embryos. (A) Sections through central retina of WT (left column) and panther mutant 
(right column) larvae at 8dpf, immunolabeled (cyan) with markers of red-green cone 
photoreceptors (ZPR1, top row) and amacrine cells (HCP1, middle row), BrdU (fusia), 
PCNA (fusia, bottom row), and DAPI (gray). (B) Histogram showing relative retinal area 
between WT control (21533.4 ± 4112.8 µm2; n=15) and panther mutant (21333.4 ± 
2365.8 µm2; n=10) larvae at 8dpf. (C) Histogram showing the number of retinal microglia 
in WT control (95.7 ± 25.7 cells; n=14) and panther mutant (5.9 ± 6.0 cells; n=15) larvae 
at 8dpf; ***p<0.001. (D) Sections through central retina of DMSO-treated control (left 
column) and PLX5622-treated (right column) larvae at 8dpf, immunolabeled (cyan) with 
markers of red-green cone photoreceptors (ZPR1, top row) and amacrine cells (HCP1, 
bottom row), BrdU (fusia), and DAPI (gray). (E) Histogram showing relative retinal area 
between DMSO-treated control (19503.8 ± 2177.6 µm2; n=10) and PLX5622-treated 
(18900.2 ± 2781.1 µm2; n=11) larvae at 8dpf. (F) Histogram showing the number of 
retinal microglia between DMSO-treated control (113 ± 43.8 cells; n=10) and PLX5622-
treated (113.9 ± 57.8 cells; n=11) larvae at 8dpf. Quantitative data are represented as 
mean; error bars reperesent the standard deviation. Outer nuclear layer (ONL); inner 
nuclear layer (INL); ganglion cell layer (GCL); ciliary marginal zone (CMZ, brackets). 
Scale bar equals 100µm.  ! !
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Figure 2.4: Treatment with PLX5622 results in altered neurogenesis in the 
developing zebrafish retina. (A-L) Transverse sections through central retina of 
DMSO-treated control (A-C; G-I) and PLX5622-treated (D-F; J-L) embryos at 48 and 
72hpf, respectively. Sections are immunolabeled with cell-specific antibody markers 
(cyan) for ganglion cells (Zn5, top row), amacrine cells (HCP1, middle row), and red-
green double cone photoreceptor cells (Zpr1, bottom row), EdU (fusia), and DAPI (gray). 
(M) Histogram showing relative retinal area of DMSO-treated control (14462 ± 1749.6 
µm2; n=10) and PLX5622-treated (10007.5 ± 1673.2 µm2; n= 14) retinas at 48hpf 
(***p≤0.001), and DMSO-treated (13901.9 ± 712.2 µm2; n=6) and PLX5622-treated 
(12857.9 ± 1524.2 µm2; n=16) retinas at 72hpf. (N) Histogram showing the percent of the 
retina labeled with EdU in DMSO-treated control (41.6 ± 5.0%; n=10) and PLX5622-
treated (73.4 ± 8.1%; n=14) embryos at 48hpf, and DMSO-treated control (13.3 ± 2.2%; 
n=6) and PLX5622-treated (35.6 ± 11.5%; n=16) embryos at 72hpf; ***p≤0.001. Data are 
represented as mean; error bars reperesent the standard deviation. Outer nuclear layer 
(ONL); inner nuclear layer (INL); and ganglion cell layer (GCL); ciliary marginal zone 
(CMZ, brackets). Scale bar equals 50µm. ! !
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Figure 2.5: Expression of pgrn-a in the developing retina and Western blot of 
Pgrn-a expressed at 24hpf. (A-D) Whole mount in situ hybridization showing pgrn-a 
expression in wild type (WT) at 24 (A), 48 (B), and 72hpf (arrowheads in C+D). Panel D 
is a higher magnification image of the eye in panel C. In each panel, the dashed line 
marks the boundary of the eye. Lens (L). (E) Western blot showing Pgrn-a and Actin 
expression in 24hpf AB WT embryos. (F-I) Cross-sections of the retina following whole 
mount in situ hybridizations showing pgrn-a expression in WT at 24 (A), 36 (B), 48 (C), 
and 72hpf (D). (J-Q) pgrn-a is microglia-specific by 72hpf. pgrn-a in situ hybridization 
(J+L) followed by immunohistochemistry of L-plastin (K) and 4C4 (M) showing co-
localization of pgrn-a and microglial markers (arrowheads). Double in situ hybridization 
in the same section showing DAPI (N), pgrn-a (O), and fms (P) expression, and overlay 
(Q) showing co-localization of pgrn-a and fms in the retina (arrowheads). Outer nuclear 
layer (ONL); inner nuclear layer (INL); and ganglion cell layer (GCL); (L) lens. Scale bar 
equals 50µm. !
